<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
<publisher>
<publisher-name>The Authors.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32783930</article-id>
<article-id pub-id-type="pmc">7418709</article-id>
<article-id pub-id-type="publisher-id">S2211-1247(20)30987-6</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2020.108002</article-id>
<article-id pub-id-type="publisher-id">108002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Garay</surname>
<given-names>Patricia M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Chen</surname>
<given-names>Alex</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Tsukahara</surname>
<given-names>Takao</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Rodríguez Díaz</surname>
<given-names>Jean Carlos</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au5">
<name>
<surname>Kohen</surname>
<given-names>Rafi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" id="au6">
<name>
<surname>Althaus</surname>
<given-names>J. Christian</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author" id="au7">
<name>
<surname>Wallner</surname>
<given-names>Margarete A.</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author" id="au8">
<name>
<surname>Giger</surname>
<given-names>Roman J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="aff" rid="aff7">7</xref>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author" id="au9">
<name>
<surname>Jones</surname>
<given-names>Kevin S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author" id="au10">
<name>
<surname>Sutton</surname>
<given-names>Michael A.</given-names>
</name>
<email>masutton@umich.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author" id="au11">
<name>
<surname>Iwase</surname>
<given-names>Shigeki</given-names>
</name>
<email>siwase@umich.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="fn" rid="fn1">10</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
<aff id="aff1"><label>1</label>Neuroscience Graduate Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA</aff>
<aff id="aff2"><label>2</label>Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA</aff>
<aff id="aff3"><label>3</label>Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA</aff>
<aff id="aff4"><label>4</label>Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA</aff>
<aff id="aff5"><label>5</label>College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109, USA</aff>
<aff id="aff6"><label>6</label>Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA</aff>
<aff id="aff7"><label>7</label>Cellular and Molecular Biology Graduate Program, University of Michigan Medical School, Ann Arbor, MI, 48109, USA</aff>
<aff id="aff8"><label>8</label>Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA</aff>
<aff id="aff9"><label>9</label>Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>masutton@umich.edu</email></corresp>
<corresp id="cor2"><label>∗∗</label>Corresponding author <email>siwase@umich.edu</email></corresp>
<fn id="fn1">
<label>10</label>
<p id="ntpara0010">Lead Contact</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>8</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="ppub">
<day>11</day>
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>32</volume>
<issue>6</issue>
<fpage>108002</fpage>
<lpage>108002</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 The Authors</copyright-statement>
<copyright-year>2020</copyright-year>
<license>
<license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
</license>
</permissions>
<abstract id="abs0010">
<title>Summary</title>
<p>Long-lasting forms of synaptic plasticity such as synaptic scaling are critically dependent on transcription. Activity-dependent transcriptional dynamics in neurons, however, remain incompletely characterized because most previous efforts relied on measurement of steady-state mRNAs. Here, we use nascent RNA sequencing to profile transcriptional dynamics of primary neuron cultures undergoing network activity shifts. We find pervasive transcriptional changes, in which ∼45% of expressed genes respond to network activity shifts. We further link retinoic acid-induced 1 (RAI1), the Smith-Magenis syndrome gene, to the transcriptional program driven by reduced network activity. Remarkable agreement among nascent transcriptomes, dynamic chromatin occupancy of RAI1, and electrophysiological properties of <italic>Rai1</italic>-deficient neurons demonstrates the essential roles of RAI1 in suppressing synaptic upscaling in the naive network, while promoting upscaling triggered by activity silencing. These results highlight the utility of bona fide transcription profiling to discover mechanisms of activity-dependent chromatin remodeling that underlie normal and pathological synaptic plasticity.</p>
</abstract>
<abstract abstract-type="graphical" id="abs0015">
<title>Graphical Abstract</title>
<fig id="undfig1" position="anchor">
<graphic xlink:href="fx1_lrg"></graphic>
</fig>
</abstract>
<abstract abstract-type="author-highlights" id="abs0020">
<title>Highlights</title>
<p>
<list id="ulist0010" list-type="simple">
<list-item id="u0010">
<label>•</label>
<p id="p0010">BrU-seq reveals nascent transcription during synaptic up- or downscaling</p>
</list-item>
<list-item id="u0015">
<label>•</label>
<p id="p0015">Smith-Magenis syndrome protein RAI1 regulates upscaling-associated transcription</p>
</list-item>
<list-item id="u0020">
<label>•</label>
<p id="p0020">RAI1 departs chromatin in response to network activity shifts</p>
</list-item>
<list-item id="u0025">
<label>•</label>
<p id="p0025">RAI1 blocks upscaling in naive networks and promotes inactivity-induced upscaling</p>
</list-item>
</list>
</p>
</abstract>
<abstract abstract-type="teaser" id="abs0025">
<p>Garay et al. adopt BrU-seq to profile bona fide transcriptional dynamics triggered by neuronal activity shifts. An integrated genomics approach including BrU-seq, combined with electrophysiology, reveals that RAI1, the Smith-Magenis syndrome protein, controls baseline synaptic strength and homeostatic synaptic upscaling by regulating the transcriptome associated with network inactivity.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>Bru-seq</kwd>
<kwd>nascent RNA</kwd>
<kwd>RAI1</kwd>
<kwd>synaptic scaling</kwd>
<kwd>activity-dependent transcription</kwd>
<kwd>Smith-Magenis Syndrome</kwd>
<kwd>chromatin regulation</kwd>
<kwd>neurodevelopmental disorders</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: August 11, 2020</p>
</notes>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p id="p0030">Proper cognitive development and brain function rely on synaptic plasticity, the ability of synapses to strengthen or weaken in response to sensory or neuromodulatory inputs. Synaptic scaling is one mechanism of plasticity, which buffers potentially destabilizing patterns of network activity (<xref ref-type="bibr" rid="bib1">Abbott and Nelson, 2000</xref>; <xref ref-type="bibr" rid="bib44">Miller and MacKay, 1994</xref>; <xref ref-type="bibr" rid="bib58">Turrigiano, 2008</xref>). In response to a sustained increase in neuronal firing rate, neurons decrease, or “scale down,” the receptivity of the neuron to excitatory neurotransmitters. Conversely, global decreases in firing rate cause neurons to “scale up” and increase synaptic efficacy. Synaptic scaling can accommodate other forms of plasticity, such as long-term potentiation (LTP), that impose long-lasting increase of individual synaptic efficacy, which left uncompensated would result in circuits that are overly active (<xref ref-type="bibr" rid="bib59">Turrigiano, 2017</xref>). Synaptic scaling plays important roles in neurodevelopment, learning, and memory (<xref ref-type="bibr" rid="bib21">Fernandes and Carvalho, 2016</xref>; <xref ref-type="bibr" rid="bib64">Yee et al., 2017</xref>). Dysregulated homeostatic plasticity is a common pathological hallmark in several neurodevelopmental disorders, including fragile X syndrome (<xref ref-type="bibr" rid="bib55">Soden and Chen, 2010</xref>), Rett syndrome (<xref ref-type="bibr" rid="bib70">Zhong et al., 2012</xref>), tuberous sclerosis (<xref ref-type="bibr" rid="bib3">Bateup et al., 2013</xref>), Kleefstra syndrome (<xref ref-type="bibr" rid="bib4">Benevento et al., 2016</xref>), and some autism spectrum conditions (<xref ref-type="bibr" rid="bib9">Bourgeron, 2015</xref>).</p>
<p id="p0035">Synaptic scaling requires <italic>de novo</italic> synthesis of RNAs and proteins that directly modulate synaptic efficacy (<xref ref-type="bibr" rid="bib5">Benito and Barco, 2015</xref>; <xref ref-type="bibr" rid="bib31">Ibata et al., 2008</xref>; <xref ref-type="bibr" rid="bib32">Igaz et al., 2002</xref>). DNA-binding transcription factors (TFs), such as cyclic AMP-response binding protein (CREB), drive transcriptional responses to neuronal activation (<xref ref-type="bibr" rid="bib62">West et al., 2002</xref>). The initial response is a rapid induction of immediate-early genes, such as <italic>Arc</italic> and <italic>Homer1</italic> (<xref ref-type="bibr" rid="bib11">Brakeman et al., 1997</xref>; <xref ref-type="bibr" rid="bib12">Bramham et al., 2008</xref>). The gene expression programs triggered by reductions in network activity involves distinct TFs, such as SRF and ELK1 (<xref ref-type="bibr" rid="bib53">Schaukowitch et al., 2017</xref>).</p>
<p id="p0040">In eukaryotic cells, transcriptional responses must occur in a refractory environment in which DNA is packaged into chromatin. The strong linkage between cognitive disorders and chromatin-regulatory genes suggests that activity-dependent chromatin reorganization is essential for proper brain development and mental health (<xref ref-type="bibr" rid="bib17">Ebert and Greenberg, 2013</xref>; <xref ref-type="bibr" rid="bib25">Guzman-Karlsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Mullins et al., 2016</xref>). Indeed, activity-dependent gene expression underlying LTP and memory requires chromatin regulators, such as histone acetyltransferases and deacetylases (<xref ref-type="bibr" rid="bib13">Campbell and Wood, 2019</xref>). A handful of chromatin regulators, TET3 DNA demethylase (<xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>), EHMT1/2 histone H3K9 methyltransferases (<xref ref-type="bibr" rid="bib4">Benevento et al., 2016</xref>), and L3MBTL1 methyl-histone binding factor (<xref ref-type="bibr" rid="bib43">Mao et al., 2018</xref>) affect synaptic scaling. Yet these molecules constitute an infinitesimal fraction of the many chromatin regulators that have genetic links to neurodevelopmental disorders. We do not know the extent to which disease-associated chromatin regulators play roles in transcription-dependent synaptic plasticity.</p>
<p id="p0045">Another unresolved issue is the precise mechanisms by which these chromatin regulators contribute to transcription. To dissect the mechanism, accurate monitoring of transcriptional responses is critical. Most prior studies have monitored steady-state mRNA levels, using qRT-PCR, cDNA microarray, and mRNA sequencing (mRNA-seq). The brain exhibits notorious complexity of post-transcriptional regulation, including activity-dependent mRNA splicing (<xref ref-type="bibr" rid="bib27">Hermey et al., 2017</xref>), mRNA decay (<xref ref-type="bibr" rid="bib63">Widagdo and Anggono, 2018</xref>), mRNA transport, and local translation (<xref ref-type="bibr" rid="bib24">Glock et al., 2017</xref>). Therefore, reliance on steady-state mRNA measurements may obscure the roles of chromatin regulators in transcription.</p>
<p id="p0050">In the present work, we developed genome-wide measurement of bona fide transcriptional dynamics in response to bidirectional network activity alterations. We then used this approach to uncover a role for the chromatin regulator retinoic acid-induced 1 (RAI1) in the transcriptional program. RAI1 is a nucleosome-binding protein (<xref ref-type="bibr" rid="bib15">Darvekar et al., 2012</xref>, <xref ref-type="bibr" rid="bib16">2013</xref>) and is expressed throughout the embryonic and adult brain (<xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>). <italic>RAI1</italic> is associated with two human intellectual disability syndromes. <italic>RAI1</italic> haploinsufficiency leads to Smith-Magenis syndrome (SMS; MIM: <ext-link ext-link-type="omim" id="intref0010" xlink:href="182290">182290</ext-link>), while <italic>RAI1</italic> duplication results in Potocki-Lupski syndrome (PTLS; MIM: <ext-link ext-link-type="omim" id="intref0015" xlink:href="610883">610883</ext-link>) (<xref ref-type="bibr" rid="bib6">Bi et al., 2004</xref>; <xref ref-type="bibr" rid="bib23">Girirajan et al., 2005</xref>; <xref ref-type="bibr" rid="bib50">Potocki et al., 2007</xref>; <xref ref-type="bibr" rid="bib54">Slager et al., 2003</xref>). Studies in mouse models and human patient cells have uncovered roles of RAI1 in gene expression, neuronal structure, and behavior (<xref ref-type="bibr" rid="bib7">Bi et al., 2005</xref>, <xref ref-type="bibr" rid="bib8">2007</xref>; <xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>, <xref ref-type="bibr" rid="bib30">2018</xref>; <xref ref-type="bibr" rid="bib37">Lacaria et al., 2013</xref>). However, no study has described RAI1 in activity-dependent transcription and synaptic plasticity to date. We therefore explored the roles of RAI1 in activity-dependent transcription and synaptic scaling.</p>
</sec>
<sec id="sec2">
<title>Results</title>
<sec id="sec2.1">
<title>Altered Neuronal Network Activity Triggers Genome-wide Transcriptional Changes</title>
<p id="p0055">To overcome the major limitation of steady-state RNA sequencing (RNA-seq), we adopted bromouridine sequencing (BrU-seq), a genome-wide profiling technique of nascent transcripts (<xref ref-type="bibr" rid="bib48">Paulsen et al., 2013</xref>, <xref ref-type="bibr" rid="bib49">2014</xref>). We prepared primary forebrain neuron cultures from embryonic day 18 (E18) mouse embryos and allowed them to mature for 17 days <italic>in vitro</italic> (DIV). To monitor bidirectional transcriptional responses to activity shifts, network activity was elevated by 20 μM bicuculline (BIC; a GABA<sub>A</sub> receptor antagonist) or suppressed by 1 μM tetrodotoxin (TTX; a sodium channel blocker) for 4 h. During the last 20 min of BIC or TTX treatment, we added BrU to the culture medium to label newly synthesized transcripts. We isolated the labeled RNAs using an anti-BrU antibody and subjected them to next-generation sequencing (<xref ref-type="fig" rid="fig1">Figure 1</xref>
A).<fig id="fig1"><label>Figure 1</label><caption><p>Genome-wide Transcriptional Response to Bidirectional Activity Alterations</p><p>(A) Experimental procedure.</p><p>(B) UCSC Browser views of BrU-seq signals at <italic>Arc</italic> and <italic>Fos</italic>. Intronic reads are characteristic of nascent RNA.</p><p>(C) Differential gene expression analysis (DESeq2) reveals widespread transcriptional changes in response to TTX and BIC (p<sub>adj</sub> &lt; 0.05).</p><p>(D) BIC-response genes show a greater median fold change (Wilcoxon rank-sum test). Whiskers represent 1.5 times the inter-quartile range (IQR), and the notch represents the 95% confidence interval of the median.</p><p>(E) Downregulation of immediate-early gene in the TTX condition is captured more sensitively in BrU-seq data compared with mRNA-seq data (<xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>).</p><p>(F) The majority of TTX and BIC response genes are uniquely regulated (70%). 24% of genes are reciprocally regulated, and 6% are commonly regulated.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref> and <xref ref-type="supplementary-material" rid="mmc2">Tables S1</xref> and <xref ref-type="supplementary-material" rid="mmc3">S2</xref>.</p></caption><graphic xlink:href="gr1_lrg"></graphic></fig></p>
<p id="p0060">Our BrU-seq dataset demonstrated the expected induction of <italic>Arc</italic> and <italic>Fos</italic> by BIC (<xref ref-type="fig" rid="fig1">Figure 1</xref>B). Abundant intronic reads indicate that detected transcripts were recently generated and yet to be spliced. Other well-characterized activity-dependent genes, such as <italic>Npas4</italic>, <italic>Egr1</italic>, <italic>Homer1</italic>, <italic>Tet3</italic>, and <italic>Txnip</italic>, also showed expected transcriptional induction (<xref ref-type="supplementary-material" rid="mmc2">Table S1</xref>). Differential gene expression analysis of the BrU-seq data using DESeq2 (<xref ref-type="bibr" rid="bib42">Love et al., 2014</xref>) revealed widespread transcriptional changes, in which 45% of expressed genes (7,592 of 16,682) were up- or downregulated by network activity shifts (p<sub>adj</sub> &lt; 0.05; <xref ref-type="fig" rid="fig1">Figure 1</xref>C). BIC increased transcription of 2,908 genes, while TTX did so for 1,820 genes. The magnitude of transcriptional induction is higher with BIC treatment compared with TTX treatment (<xref ref-type="fig" rid="fig1">Figure 1</xref>D). To examine the relationship between nascent and steady-state transcriptomes, we compared our BrU-seq data with published mRNA-seq datasets of mouse cortical neurons treated with TTX or BIC for 4 or 6 h (<xref ref-type="bibr" rid="bib53">Schaukowitch et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>) with identical data processing. Our 4 h BrU-seq results showed a much stronger similarity with 4 h mRNA-seq than 6 h mRNA-seq data (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>B). Thus, BrU-seq reliably captures known transcriptional responses to bidirectional shifts in network activity.</p>
<p id="p0065">BrU-seq might be a better approach than mRNA-seq to detect downregulation of transcription, because the persistence of RNAs after transcription does not contribute to BrU-seq signals. Indeed, we found significantly larger suppression of <italic>Fos</italic>, <italic>Arc</italic>, <italic>Bdnf</italic>, and <italic>Npas4</italic> (4- to 16-fold) by TTX treatment in BrU-seq compared with mRNA-seq performed with 4 h BIC and TTX treatments, in which downregulation was less than 2-fold (<xref ref-type="fig" rid="fig1">Figure 1</xref>E) (<xref ref-type="bibr" rid="bib53">Schaukowitch et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>). The magnitude of upregulation in response to BIC was smaller in BrU-seq, likely because the early transcriptional induction is largely complete 4 h after BIC treatment. At a genome-wide scale, BrU-seq allowed us to detect transcriptional suppression of numerous genes (BIC, n = 2,842; TTX, n = 2,307). These data highlight an advantage of the BrU-seq approach to probe mechanisms underlying highly dynamic activity-dependent transcription.</p>
<p id="p0070">On the basis of the behavior of well-defined activity-response genes (<xref ref-type="fig" rid="fig1">Figure 1</xref>E), one could assume that BIC and TTX trigger reciprocal transcriptional responses. Unexpectedly, only a small fraction of activity-response genes (24% [1,798 of 7,592]) displayed such mirrored responses between BIC and TTX treatments (<xref ref-type="fig" rid="fig1">Figure 1</xref>F). Six percent of activity-response genes (487 of 7,592) altered their transcription levels in the same direction after BIC and TTX treatments. The remaining majority of genes (70% [5,307 of 7,592]) responded to BIC or TTX uniquely. These data suggest that synaptic up- and downscaling involves distinct transcriptional programs. <xref ref-type="supplementary-material" rid="mmc2">Table S1</xref> lists genes that displayed greater than 2-fold changes in transcription upon network activity shifts.</p>
<p id="p0075">Recent studies have reported that different cell types, such as astrocytes and neuronal subtypes, induce distinct sets of genes in an activity-dependent manner (<xref ref-type="bibr" rid="bib26">Hasel et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Hrvatin et al., 2018</xref>). We sought to assess the contribution of various cell types in our datasets. Using immunocytochemistry of a set of cell type markers, NeuN, GAD67, GFAP, CD11b, and Olig2, we estimated that our cultures comprise 41% excitatory neurons, 11% inhibitory neurons, 33% astrocytes, 15% of cells within the oligodendrocyte lineage, and no microglia (<xref ref-type="supplementary-material" rid="mmc1">Figures S1</xref>D and S1E). We found several non-neuronal genes in our dataset, including <italic>Thbs1</italic>, a synaptic regulator expressed specifically in astrocytes (<xref ref-type="bibr" rid="bib51">Risher and Eroglu, 2012</xref>). We detected enrichment of biological processes specific for both neurons and non-neuronal cell types (<xref ref-type="supplementary-material" rid="mmc3">Table S2</xref>). Intersection of the BrU-seq data with published cell-type-enriched genes (<xref ref-type="bibr" rid="bib69">Zhang et al., 2014</xref>) revealed that the majority (&gt;80%) of the activity-response genes do not exhibit cell type-specific expression (<xref ref-type="supplementary-material" rid="mmc1">Figure S1</xref>F). Thus, the present dataset represents an aggregate view of transcriptional response occurring in multiple cell types.</p>
</sec>
<sec id="sec2.2">
<title>RAI1 Suppresses the TTX-Induced Transcriptional Program in Resting Networks</title>
<p id="p0080">RAI1 is one of many chromatin regulators that are mutated in neurodevelopmental disorders. Little is known about RAI1’s roles in activity-dependent transcription and synaptic plasticity. We developed an anti-RAI1 antibody and confirmed that RAI1 protein was present in virtually all MAP2-positive neurons and primarily localized to the nucleus, with subtle signals in the soma (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A). We found lower RAI1 levels in non-neuronal (MAP2-negative) cell nuclei (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A), highlighting its important role in neurons. Widespread presence of RAI1 in neurons is consistent with previous studies (<xref ref-type="bibr" rid="bib22">Fragoso et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>) (<xref ref-type="supplementary-material" rid="mmc1">Figures S2</xref>B and S2C).</p>
<p id="p0085">Having established nascent transcriptional profiling in neural ensembles and the presence of RAI1 in our cultures, we sought to test if RAI1 has any roles in synaptic scaling and transcriptional responses to altered neuronal activity. We knocked down <italic>Rai1</italic> in primary cortical cultures using lentiviral vectors (LVs) carrying <italic>Rai1</italic> or scrambled short hairpin RNAs (shRNAs) (sh-Ctrl). To minimize the impact of RAI1 loss on network connectivity, we delivered LV shRNA at DIV 14, a time by which functional synapses have formed. The knockdown (KD) achieved near complete loss of RAI1 protein by 3 days post-LV infection (<xref ref-type="fig" rid="fig2">Figure 2</xref>
A). We then modulated network activity of LV-treated cultures by applying TTX or BIC for 4 h and carried out BrU-seq as described above.<fig id="fig2"><label>Figure 2</label><caption><p><italic>Rai1</italic> KD Alters Transcription of TTX-Response Genes at Baseline</p><p>(A) Validation of <italic>Rai1</italic> KD with western blot. Mouse forebrain neuron cultures were transduced with lentivirus expressing sh-<italic>Rai1</italic> or sh-Ctrl for 3 days.</p><p>(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl versus sh-<italic>Rai1</italic>, p<sub>adj</sub> &lt; 0.05) after vehicle treatment.</p><p>(C) Many <italic>Rai1</italic>-KD DE genes are TTX- and BIC-response genes.</p><p>(D) The fold changes of TTX- and BIC-response genes by <italic>Rai1</italic> KD at baseline. Note that <italic>Rai1</italic>-KD cultures display a transcriptional profile similar to TTX-treated control cultures. r, Spearman’s rank correlation coefficient.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref> and <xref ref-type="supplementary-material" rid="mmc4">Tables S3</xref> and <xref ref-type="supplementary-material" rid="mmc5">S4</xref>.</p></caption><graphic xlink:href="gr2_lrg"></graphic></fig></p>
<p id="p0090">We initially tested if <italic>Rai1</italic> KD alters nascent transcription in control “resting” neuronal cultures with stable basal levels of activity. DESeq2 analysis revealed 122 differentially expressed (DE) genes: 104 downregulated and 18 upregulated following <italic>Rai1</italic> KD (p<sub>adj</sub> &lt; 0.05; <xref ref-type="fig" rid="fig2">Figure 2</xref>B; <xref ref-type="supplementary-material" rid="mmc4">Table S3</xref>). The finding that <italic>Rai1</italic> KD downregulates more genes than it upregulates is consistent with the previous studies on RAI1 (<xref ref-type="bibr" rid="bib19">Elsea and Williams, 2011</xref>; <xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>). A majority of genes altered by <italic>Rai1</italic> KD at baseline were BIC- or TTX-response genes (<xref ref-type="fig" rid="fig2">Figure 2</xref>C). To further characterize the relationship between RAI1 deficiency and BIC- or TTX-response genes, we examined how individual genes behave upon <italic>Rai1</italic> KD. We found a clear positive correlation between the normal transcriptional response to TTX and the transcriptional impairment by <italic>Rai1</italic> KD at baseline (Spearman rank correlation coefficient r = 0.53, t test p = 2.2 × 10<sup>−16</sup>; <xref ref-type="fig" rid="fig2">Figure 2</xref>D, left panel). BIC-response genes showed no correlation with <italic>Rai1</italic> KD (<xref ref-type="fig" rid="fig2">Figure 2</xref>D, right panel). The group of genes that respond reciprocally to TTX and BIC (<xref ref-type="fig" rid="fig1">Figure 1</xref>F) showed a similar correlation as there was with all TTX-responsive genes (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>D). When we removed all DE genes upon <italic>Rai1</italic> KD from the plot, the correlation remained significant (r = 0.52, p = 2.2 × 10<sup>−16</sup>; <xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>E), suggesting that the DE genes are not the sole driver for the observed correlation. We also analyzed the published mRNA-seq of the <italic>Rai1</italic>-knockout (KO) cortices (<xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>) and found a similar trend in expression pattern of the TTX- and BIC-response genes <italic>in vivo</italic> (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>F). These data show that RAI1 deficiency shifts the transcriptional profile toward the TTX-treated state without drug application and that <italic>Rai1</italic> KD does not affect transcription of non-reciprocal BIC-responsive genes.</p>
</sec>
<sec id="sec2.3">
<title>RAI1 Deficiency Promotes Synaptic Upscaling</title>
<p id="p0095">Chronic perturbation of neuronal activity by BIC or TTX induces decreases and increases in synaptic strength, which respectively underlie homeostatic synaptic downscaling and upscaling (<xref ref-type="bibr" rid="bib1">Abbott and Nelson, 2000</xref>; <xref ref-type="bibr" rid="bib44">Miller and MacKay, 1994</xref>; <xref ref-type="bibr" rid="bib58">Turrigiano, 2008</xref>). Given that <italic>Rai1</italic> KD shifted the nascent transcriptome toward the TTX-like state, we asked whether <italic>Rai1</italic> KD would similarly shift excitatory synapse function toward a state similar to synaptic upscaling. We used sparse transfection of DIV 12–14 hippocampal cultures with either <italic>Rai1</italic> or scrambled shRNA and recorded miniature excitatory postsynaptic currents (mEPSCs) from transfected pyramidal-like neurons 48 h later. If <italic>Rai1</italic> KD induces synaptic strengthening in a cell-autonomous manner, we would expect to see a rightward shift in the distribution of mEPSC amplitudes as is observed during synaptic upscaling following chronic activity suppression with TTX. Consistent with this idea, we found that the expression of two distinct shRNAs targeting <italic>Rai1</italic> mRNA each induced a significant increase in baseline mEPSC amplitude (<xref ref-type="fig" rid="fig3">Figures 3</xref>A and 3B), without significantly altering mEPSC frequency or decay time (<xref ref-type="fig" rid="fig3">Figures 3</xref>C and 3D; <xref ref-type="supplementary-material" rid="mmc1">Figures S3</xref>A–S3E). Moreover, <italic>Rai1</italic> KD induced a clear rightward shift in the cumulative probability distribution of mEPSC amplitudes relative to control neurons (<xref ref-type="fig" rid="fig3">Figure 3</xref>E; <xref ref-type="supplementary-material" rid="mmc1">Figure S3</xref>E), an effect that was significantly (albeit partially) rescued by expression of RNAi-resistant RAI1 (F[2, 41] = 4.452, p = 0.017; sh-Ctrl, sh-<italic>Rai1</italic> #1, and rescue, n = 15, 15, and 14; sh-Ctrl versus sh-<italic>Rai1</italic> #1, p = 0.068; sh-<italic>Rai1</italic> #1 versus rescue, p = 0.0359; sh-Ctrl versus sh-<italic>Rai1</italic> #2, n = 14-13, p = 0.0012; <xref ref-type="fig" rid="fig3">Figures 3</xref>A–3E). The shift in distribution of mEPSC amplitudes with <italic>Rai1</italic> KD bears a striking similarity to changes in mEPSC distributions following chronic TTX treatment (<xref ref-type="fig" rid="fig3">Figure 3</xref>F), although <italic>Rai1</italic> KD did not shift mEPSC amplitudes to quite the same degree as TTX. An increase in surface expression of AMPA receptors (AMPARs) at synapses is a signature of synaptic upscaling following activity suppression. Consistent with previous observations, surface expression of the GluA1 AMPAR subunit at PSD-95-labeled excitatory synapses is significantly increased following long-term (24 h) TTX treatment (sh-Ctrl vehicle [Veh] versus TTX, n = 13-12, p = 0.0019; <xref ref-type="fig" rid="fig3">Figure 3</xref>G); likewise, we found a similar enhancement of surface GluA1 at synapses following 72 h <italic>Rai1</italic> KD (sh-Ctrl versus sh-<italic>Rai1</italic>, n = 6-6, p = 0.0065; <xref ref-type="fig" rid="fig3">Figure 3</xref>G). Together, these results suggest that reduced <italic>Rai1</italic> expression induces functional changes in excitatory synaptic function that mimic synaptic upscaling induced by activity suppression.<fig id="fig3"><label>Figure 3</label><caption><p><italic>Rai1</italic> KD Increases Synaptic Efficacy at Baseline Activity Condition</p><p>(A–D) Example traces (A) and mean ± SEM mEPSC amplitude (B), frequency (C), and decay time (D) for cultured rat hippocampal primary neurons recorded after transient transfection (48 h) with non-targeting shRNA (sh-Ctrl), <italic>Rai1</italic> targeting shRNA, or sh-<italic>Rai1</italic> #1 with RNAi-resistant <italic>Rai1</italic>-expressing construct (rescue) at DIV 12–14. Scale bar, 10 pA, 75 ms (sh-Ctrl, sh-<italic>Rai1</italic> #1, and Rescue, n = 15, 15, and 14, respectively).</p><p>(E) Cumulative distribution of mEPSC amplitudes of sh-Ctrl (left), sh-<italic>Rai11</italic> (middle), and rescue (right) transfected neurons.</p><p>(F) Cumulative distribution of mEPSC amplitudes of sh-Ctrl-transfected neurons treated by either vehicle or 1 μM TTX (left) and sh-Ctrl or sh-<italic>Rai1</italic>-transfected neurons (right).</p><p>(G) Representative images of surface GluA1 (sGluA1, fire), PSD-95 (green), and sGluA1 and PSD-95 (merge) of sh-Ctrl and sh-<italic>Rai1</italic>-infected dendrites. Scale bar, 10 μm. Bar graph of mean sGluA1 signal intensity in PSD-95-positive regions for vehicle or TTX (n = 13-12) and sh-Ctrl or sh-<italic>Rai1</italic> (n = 6-6) treated neurons.</p><p>(H) Prototypical local field potential recordings from individual electrodes exhibiting a single neuronal unit from cultures transfected with: sh-Ctrl, sh-<italic>Rai1</italic> #1, or sh-<italic>Rai1</italic> #2 lentivirus. Scale bars, 500 ms (x axis) and 20 μV (y axis).</p><p>(I) Firing frequency of individual neuronal units recorded from cultures transfected with sh-Ctrl, sh-<italic>Rai1</italic> #1, or sh-<italic>Rai1</italic> #2 (n = 115, 140, and 131 for sh-Ctrl, sh-<italic>Rai1</italic> #1, and sh-<italic>Rai1</italic> #2, respectively).</p><p>All bar graphs represent mean ± SEM. For (B)–(D), one-way ANOVA, followed by post hoc Fisher’s least significant difference (LSD) test were performed. For (G), unpaired Student’s t tests were performed. For (I), Kruskal-Wallis (K-W) test followed by post hoc Dunn’s multiple-comparisons test was performed. K-W: 9.358, p = 0.0003. <sup>∗</sup>p &lt; 0.05, <sup>∗∗</sup>p &lt; 0.01, and <sup>∗∗∗</sup>p &lt; 0.001. See also <xref ref-type="supplementary-material" rid="mmc1">Figure S3</xref>.</p></caption><graphic xlink:href="gr3_lrg"></graphic></fig></p>
<p id="p0100">Two scenarios could explain the increase in mEPSC amplitude by <italic>Rai1</italic> KD accompanied by TTX-like transcription in resting neurons. The first possibility is that <italic>Rai1</italic> KD suppresses network activity, which in turn indirectly promotes a TTX-like transcriptional program and synaptic upscaling. An alternative possibility is that release of RAI1-mediated suppression of a TTX-responsive transcriptional program directly upscales synapse function. To distinguish these possibilities, we measured ongoing basal network activity of control hippocampal cultures and <italic>Rai1</italic> KD cultures using 60-channel microelectrode arrays (MEAs; <xref ref-type="supplementary-material" rid="mmc1">Figures S3</xref>F and S3G). On DIV 11, we transduced the cultures with LV control or <italic>Rai1</italic> shRNA and recorded network activity on DIV 14. We used semi-automatic principal-component analysis to sort individual neuronal units (<xref ref-type="supplementary-material" rid="mmc1">Figures S3</xref>H–S3K). If the changes in mEPSCs and transcriptional dynamics are an indirect effect secondary to <italic>Rai1</italic> KD suppressing network activity, then we would predict a marked decrease in neural firing. Contrary to this prediction, <italic>Rai1</italic> KD did not suppress firing in the network and instead led to 1.4- to 2.1-fold increase in spontaneous firing rate compared with scrambled shRNA (<xref ref-type="fig" rid="fig3">Figures 3</xref>H and 3I; Kruskal-Wallis test: 9.36, p = 0.009; Dunn’s post hoc test: sh-Ctrl versus sh-<italic>Rai1</italic> #1, p = 0.053; sh-Ctrl versus sh-<italic>Rai1</italic> #2, p = 0.010), likely because of enhanced excitatory drive that accompanies <italic>Rai1</italic> KD-mediated synaptic strengthening. These data thus support the second explanation, whereby RAI1 suppresses a TTX-responsive transcriptional program and synaptic upscaling in naive neural networks.</p>
</sec>
<sec id="sec2.4">
<title>RAI1 Promotes Transcriptional Responses Triggered by Reductions in Network Activity</title>
<p id="p0105">Having uncovered that RAI1 was essential to suppress the TTX-associated transcriptional program under basal activity conditions (<xref ref-type="fig" rid="fig2">Figure 2</xref>), we next tested if <italic>Rai1</italic> KD has any impact on transcriptional responses to TTX and BIC treatments. By calculating fold changes of transcription, we found that <italic>Rai1</italic> KD led to a significant impairment of transcriptional response to TTX, while transcriptional responses to BIC were slightly weaker only for downregulation (<xref ref-type="fig" rid="fig4">Figure 4</xref>
A). However, in contrast to the 130 genes transcriptionally altered at baseline, DESeq2 comparing <italic>Rai1</italic> KD and control revealed only 8 DE genes after TTX or BIC treatment, indicating that the impact of <italic>Rai1</italic> KD is greater in resting neurons compared with drug-treated neurons (<xref ref-type="fig" rid="fig4">Figure 4</xref>B; <xref ref-type="supplementary-material" rid="mmc4">Table S3</xref>).<fig id="fig4"><label>Figure 4</label><caption><p>RAI1 Positively Regulates the Transcriptional Response to TTX</p><p>(A) The fold changes of TTX- and BIC-response genes in cultures treated by sh-Ctrl or sh-<italic>Rai1</italic> (Wilcoxon rank-sum test). Whiskers represent 1.5 times IQR, and the notch represents the 95% confidence interval of the median.</p><p>(B) Number of DESeq2-called differentially expressed genes (sh-Ctrl versus sh-<italic>Rai1</italic>, p<sub>adj</sub> &lt; 0.05) after TTX, vehicle, or BIC treatment.</p><p>(C) Incomplete downregulation and upregulation of genes by TTX (left) but not by BIC (right) in <italic>Rai1</italic>-KD cultures. r and p, Spearman’s rank correlation coefficient and p value.</p><p>(D) RAI1-dependent gene ontologies (biological process, p<sub>adj</sub> &lt; 0.005) discovered using RNA-Enrich (<xref ref-type="bibr" rid="bib40">Lee et al., 2016</xref>) and filtered using ReviGO software (<xref ref-type="bibr" rid="bib56">Supek et al., 2011</xref>).</p><p>(E) RPKM (reads per kilobase of transcript per million mapped reads) values of four Sig-genes downregulated by <italic>Rai1</italic> KD in the TTX-treated condition. The Sig-genes represent “neurotransmitter transport” (p<sub>adj</sub> = 9.3 × 10<sup>−8</sup>), the top downregulated biological processes. The remaining Sig-genes are shown in Figure S7. Note slight but consistent inter-replicate changes upon <italic>Rai1</italic> KD.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref> and <xref ref-type="supplementary-material" rid="mmc4">Tables S3</xref> and <xref ref-type="supplementary-material" rid="mmc5">S4</xref>.</p></caption><graphic xlink:href="gr4_lrg"></graphic></fig></p>
<p id="p0110">We then sought to determine if the strongly impaired transcriptional response to TTX (<xref ref-type="fig" rid="fig4">Figure 4</xref>A) was due entirely to the TTX-like transcriptional state of <italic>Rai1</italic>-KD cultures at baseline or if RAI1 also contributes to the transcriptional response to TTX. Differential gene expression analysis by DESeq2 relies on an arbitrary statistical significance cutoff to report DE genes. However, the individual gene plot in the baseline condition revealed a global transcriptional trend resulting from minor changes in many genes, including those that failed to achieve statistical significance (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>E). To define the impact of RAI1 loss after TTX and BIC treatment, we therefore used this individual gene plot approach. We found that after TTX treatment, the transcriptional changes of TTX-response genes in <italic>Rai1</italic>-KD cultures inversely correlated with their changes upon TTX treatment in the control condition (<xref ref-type="fig" rid="fig4">Figure 4</xref>C, left panel; Spearman rank correlation coefficient r = 0.32, t test p = 2.2 × 10<sup>−16</sup>). This result indicates incomplete downregulation and upregulation upon TTX treatment independent of the impact of <italic>Rai1</italic> KD in the resting state. The same TTX-response genes did not show obvious changes after BIC treatment of <italic>Rai1-</italic>KD culture (<xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>A, left panel). Transcription of the BIC-response genes did not show changes by <italic>Rai1</italic> KD under any condition (<xref ref-type="fig" rid="fig4">Figure 4</xref>C, right panel; <xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>A, right panel). Thus, <italic>Rai1</italic> deficiency leads to a subtle yet widespread impairment of the transcriptional response to TTX but not to BIC. Taken together, these results led us to conclude that RAI1 is selectively required for the transcriptional response driven by network activity suppression.</p>
<p id="p0115">We then explored biological implications for the impaired transcriptional response to TTX. We used RNA-Enrich, a Gene Ontology algorithm, which takes into account weaker changes in gene expression (<xref ref-type="bibr" rid="bib35">Kim et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Lee et al., 2016</xref>). Notably, RNA-Enrich identified many more RAI1-dependent biological processes after TTX treatment than vehicle or BIC treatment (45 in TTX-treated cultures, 3 in Veh-treated cultures, and 7 in BIC-treated cultures; <xref ref-type="fig" rid="fig4">Figure 4</xref>D). The p<sub>adj</sub> values were evidently lower in the post-TTX transcriptome data compared with BIC conditions. The RAI1-dependent gene ontologies after TTX treatment represent synapse-related processes, whereas those altered in the BIC and Veh-treated conditions show fewer ontologies directly relevant to neuronal activity (<xref ref-type="fig" rid="fig4">Figure 4</xref>D; <xref ref-type="supplementary-material" rid="mmc5">Table S4</xref>). RNA-Enrich provides the identity of signature genes, called Sig-genes, which contributed to the enrichment of an ontology (<xref ref-type="bibr" rid="bib35">Kim et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Lee et al., 2016</xref>). As expected, Sig-genes for the synapse-related ontologies, including <italic>Ngf</italic>, <italic>Syn3</italic>, <italic>Cacna1b</italic>, and <italic>Rab3a</italic>, showed mild yet reproducible transcriptional changes upon <italic>Rai1</italic> KD (<xref ref-type="fig" rid="fig4">Figure 4</xref>E; <xref ref-type="supplementary-material" rid="mmc1">Figure S4</xref>B).</p>
</sec>
<sec id="sec2.5">
<title>RAI1 Dissociates from Chromatin in Response to Activity Changes</title>
<p id="p0120">The activity state-dependent requirement of RAI1 in regulating transcription led us to hypothesize that activity shifts of neuronal network might alter RAI1 distribution on chromatin. To test this, we performed chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) for RAI1 in DIV 17 neuronal cultures treated for 4 h with TTX, BIC, or vehicle. We observed clear RAI1 binding at the promoters of RAI1-dependent genes such as <italic>Homer1</italic> and <italic>Per2</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>
A). The control ChIP using <italic>Rai1</italic>-KD cultures showed no such events, demonstrating the specificity of ChIP experiments. RAI1 binding was much weaker in TTX- or BIC-treated cultures (<xref ref-type="fig" rid="fig5">Figure 5</xref>A). Consistent with visual observations, peak calling identified only 13 RAI1 peaks across all three <italic>Rai1</italic>-KD ChIP-seq samples (not shown), and they were removed from all subsequent analyses. In shCtrl cells, 6,065 RAI1 peaks were found in the Veh-treated condition, and a drastic reduction of RAI1 peaks upon TTX (98 peaks) and BIC (1 peak) treatments (<xref ref-type="fig" rid="fig5">Figure 5</xref>B). Variable ChIP efficiency or sequencing depth cannot explain the scarce peaks in TTX and BIC conditions, because we spiked in <italic>Drosophila</italic> chromatin and fly-specific H2Av antibody and ensured consistent sequencing depth and ChIP efficiency across the samples (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>A). Neither RAI1 protein levels (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>B) nor nuclear localization (<xref ref-type="supplementary-material" rid="mmc1">Figure S2</xref>A) changed after TTX or BIC treatment. Thus, activity alterations largely release RAI1 from chromatin, which is remarkably consistent with the greater number of RAI1-dependent genes in resting neurons (<xref ref-type="fig" rid="fig4">Figure 4</xref>B).<fig id="fig5"><label>Figure 5</label><caption><p>Activity-Dependent Chromatin Engagement of RAI1</p><p>(A) UCSC Browser view of RAI1 ChIP-seq signals at <italic>Rai1</italic>-dependent genes <italic>Homer1</italic> and <italic>Per2</italic>.</p><p>(B) Number of RAI1 peaks in TTX-, vehicle-, and BIC-treated cultures.</p><p>(C) RAI1-bound promoters are enriched for activity-response genes (chi-square test, p = 2.2 × 10<sup>−16</sup>).</p><p>(D) Bimodal RAI1 distribution around TSS. H3K4me3, H3K4me1, H3K27me3, and H3K27ac levels are plotted as controls (see <xref ref-type="sec" rid="sec3">STAR Methods</xref>).</p><p>(E) Activity-dependent TF motifs enriched in RAI1 peaks.</p><p>(F) RAI1 directly up- and downregulates transcription in the naive culture.</p><p>(G) RAI1-bound genes in the TTX condition show incomplete induction and suppression by TTX in <italic>Rai1</italic> KD cells.</p><p>See also <xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref> and <xref ref-type="supplementary-material" rid="mmc1">Table S5</xref>.</p></caption><graphic xlink:href="gr5_lrg"></graphic></fig></p>
</sec>
<sec id="sec2.6">
<title>RAI1 Directly Controls Activity-Responsive Gene Transcription in Stable Networks</title>
<p id="p0125">Intersection with BrU-seq data revealed that that RAI1-bound genes are much more likely responsive to network activity shifts than RAI1-free genes (p &lt; 2.2 × 10<sup>−16</sup>, chi-square test; <xref ref-type="fig" rid="fig5">Figure 5</xref>C; <xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>C). Consistently, RAI1-bound genes associated with plasticity-related ontologies including synapse organization (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>D). Most of these peaks are present at the promoters in the resting culture (<xref ref-type="fig" rid="fig5">Figure 5</xref>B) and exhibited a bimodal distribution around transcription start sites (TSSs) that harbor H3K4me3 (<xref ref-type="fig" rid="fig5">Figure 5</xref>D). Binding motifs of activity-dependent TFs (e.g., MEF2A, AP1, LHX2, CREB3L) are enriched in RAI1-bound promoters (<xref ref-type="fig" rid="fig5">Figure 5</xref>D). RAI1 also occupied intra- and intergenic regions. In the resting culture, 54% of such non-promoter regions overlapped with DNase-I hypersensitivity sites (DHSs) identified in 8-week-old mouse whole brain (<xref ref-type="bibr" rid="bib61">Vierstra et al., 2014</xref>), and the rest were DHS free (<xref ref-type="fig" rid="fig5">Figure 5</xref>B). Some RAI1-bound DHS coincided with H3K4me1 or H3K27ac (<xref ref-type="bibr" rid="bib14">Creyghton et al., 2010</xref>), indicating that these elements are likely transcriptional enhancers (<xref ref-type="fig" rid="fig5">Figure 5</xref>B; see <xref ref-type="sec" rid="sec3">STAR Methods</xref>). A substantial fraction (67%) of RAI1 peaks overlapped with previously reported RAI1 peaks in adult mouse brain (<xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>) with common TF motifs (<xref ref-type="supplementary-material" rid="mmc1">Figures S5</xref>E and S5F). In sum, these analyses show that RAI1 preferentially engages activity-responsive promoters with H3K4me3 in neural networks with stable basal levels of activity.</p>
<p id="p0130">Are the RAI1-dependent genes found in BrU-seq direct targets of RAI1? Of the genes up- or downregulated by <italic>Rai1</italic> KD, RAI1 occupied 40 of 122 genes (30%) in the baseline culture, which is significantly higher than the genomic average (p &lt; 0.05, chi-square test; <xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>G). The direct targets of RAI1 can be up- or downregulated upon RAI1 loss (<xref ref-type="supplementary-material" rid="mmc1">Table S5</xref>). Of the 18 genes upregulated by <italic>Rai1</italic> KD, RAI1 binds to 10 promoters (<xref ref-type="fig" rid="fig5">Figure 5</xref>F), while RAI1 occupies 29 of 104 genes downregulated by <italic>Rai1</italic> KD. These results support the idea that RAI1 uses both positive and negative regulation to repress the TTX-like transcription state in cultures with stable basal levels of activity (<xref ref-type="fig" rid="fig2">Figures 2</xref>B–2D). Of note, BIC-response genes, which show no dependence on RAI1, also showed RAI1 peak enrichment (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>C); therefore, RAI1 at these genes is dispensable for suppressing BIC-triggered transcription.</p>
</sec>
<sec id="sec2.7">
<title>RAI1 Directly Contributes to Transcriptional Response to TTX</title>
<p id="p0135">Finally, we inspected the 98 RAI1 peaks found in TTX-treated cultures, because we detected a compromised transcriptional response of <italic>Rai1</italic>-KD cells to TTX (<xref ref-type="fig" rid="fig4">Figures 4</xref>C–4E). Most of these peaks were common between the TTX and vehicle conditions (promoter-occupied, 89% overlap; non-promoter-occupied, 77% overlap; <xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>H). We found a much greater proportion of non-promoter peaks (60%) compared with the resting cells (22%) (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>I). Thus, RAI1 at non-promoter regions preferentially persists when network activity decreases. The genes bound or nearest to these RAI1-TTX peaks showed incomplete induction and suppression upon TTX treatment of <italic>Rai1</italic>-KD cultures (<xref ref-type="fig" rid="fig5">Figure 5</xref>G) but not upon BIC treatment (<xref ref-type="supplementary-material" rid="mmc1">Figure S5</xref>J). These results suggest that RAI1 directly contributes to the transcriptional response (both negative and positive) to TTX and that this role involves primarily non-promoter regulation.</p>
</sec>
<sec id="sec2.8">
<title>Loss of RAI1 Prevents Synaptic Upscaling but Not Downscaling</title>
<p id="p0140">We next examined RAI1’s role in homeostatic synaptic scaling induced by chronic activity suppression (TTX, 24 h) or chronic network hyperactivation (BIC, 24 h). Consistent with the misregulation of TTX-responsive genes by <italic>Rai1</italic> KD after TTX treatment (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>), we found that loss of RAI1 significantly impaired the induction of homeostatic upscaling during activity suppression in a cell-autonomous manner. Following transfection of scrambled or <italic>Rai1</italic>-targeted shRNAs (24 h prior to TTX/BIC), we found that control neurons expressing the scrambled shRNA exhibited the normal increase in mEPSC amplitude 24 h post-TTX (sh-Ctrl Veh versus TTX, n = 29-21, p &lt; 0.0001; <xref ref-type="fig" rid="fig6">Figures 6</xref>A and 6B) and the distribution of mEPSCs exhibited a clear and multiplicative rightward shift in cumulative frequency plots. In contrast, mEPSCs from neurons expressing either of two distinct <italic>Rai1</italic> shRNAs did not significantly increase following TTX exposure (<xref ref-type="fig" rid="fig6">Figures 6</xref>A–6C). Importantly, expression of an RNAi-resistant RAI1 fully rescued TTX-induced upscaling (<xref ref-type="fig" rid="fig6">Figures 6</xref>A–6C). Despite a clear role in homeostatic upscaling, <italic>Rai1</italic> KD had no effect on the induction of homeostatic downscaling following network hyperactivation with BIC (<xref ref-type="fig" rid="fig6">Figures 6</xref>D–6F). Both control neurons expressing scrambled shRNA and those neurons expressing <italic>Rai1</italic> shRNA exhibited significantly decreased mEPSC amplitudes (sh-Ctrl Veh versus BIC, n = 26-17, p = 0.0026; sh-<italic>Rai1</italic>-#1 Veh versus BIC, n = 21-8, p = 0.0003; and sh-<italic>Rai1</italic>-#2 Veh versus BIC, n = 12-8, p &lt; 0.0001; <xref ref-type="fig" rid="fig6">Figure 6</xref>E), as well as a clear leftward multiplicative shift in mEPSC cumulative probability distributions (<xref ref-type="fig" rid="fig6">Figure 6</xref>F). These results demonstrate that RAI is essential for homeostatic upscaling during activity suppression but is otherwise dispensable for homeostatic downscaling during periods of network hyperactivation.<fig id="fig6"><label>Figure 6</label><caption><p><italic>Rai1</italic> KD Impairs Synaptic Upscaling but Not Synaptic Downscaling</p><p>(A–C) Representative mEPSC traces recorded from neurons transfected with sh-Ctrl, sh-<italic>Rai1</italic>, or rescue and treated with either vehicle or 1 μM TTX. Scale bar, 20 pA, 150 ms.</p><p>(B) mEPSC amplitude of sh-Ctrl, sh-<italic>Rai1</italic> #1, sh-<italic>Rai1</italic> #2, or rescue and treated either with vehicle or TTX (sh-Ctrl Veh, TTX n = 29-21; sh-<italic>Rai1</italic> #1 Veh, TTX n = 22-7; sh-<italic>Rai1</italic> #2 Veh, TTX n = 9-8; and rescue Veh, TTX n = 14-15).</p><p>(C) Cumulative distribution of mEPSC amplitude for sh-Ctrl (left), <italic>Rai1</italic> KD (sh-<italic>Rai1</italic> #1 + #2, middle), and rescue (right) comparing vehicle versus TTX.</p><p>(D–F) Representative mEPSC traces recorded from neurons transfected with either sh-Ctrl or sh-<italic>Rai1</italic> and treated with either vehicle or 10 μM BIC (D). Scale bar, 20 pA, 150 ms. (E) mEPSC amplitude of sh-Ctrl, sh-<italic>Rai1</italic> #1, and sh-<italic>Rai1</italic> #2 treated either with vehicle or BIC (sh-Ctrl Veh, BIC n = 26-17; sh-<italic>Rai1</italic> #1 Veh, BIC n = 21-8; sh-<italic>Rai1</italic> #2 Veh, BIC n = 12-8). (F) Cumulative distribution of mEPSC amplitude of sh-Ctrl (left) and sh-<italic>Rai1</italic> (sh-<italic>Rai1</italic> #1 + #2) treated with vehicle (black) or BIC (blue).</p><p>All bar graphs are represented as mean ± SEM, and unpaired Student’s t tests were performed. <sup>∗∗</sup>p &lt; 0.01, <sup>∗∗∗</sup>p &lt; 0.001, and <sup>∗∗∗∗</sup>p &lt; 0.0001.</p></caption><graphic xlink:href="gr6_lrg"></graphic></fig></p>
</sec>
<sec id="sec2.9">
<title>Discussion</title>
<p id="p0145">Our BrU-seq analysis has provided insights into activity-dependent transcriptional regulation. We found widespread transcriptional responses to network activity shifts attributable to BrU-seq’s high sensitivity in detecting transcriptional downregulation. Most dynamically regulated genes altered by hyperactivity or suppression are unique rather than reciprocal (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This is interesting given that gene expression studies have focused on reciprocal regulation of genes (e.g., <italic>Arc</italic>, <italic>Fos</italic>, <italic>Homer1</italic>, and <italic>Bdnf</italic>) (<xref ref-type="bibr" rid="bib46">Okuno, 2011</xref>). Our results agree with a nascent proteome study on rat hippocampal neurons, in which the authors observed unique, common, and reciprocal changes in protein synthesis upon TTX and BIC treatments (<xref ref-type="bibr" rid="bib52">Schanzenbächer et al., 2016</xref>). These observations suggest that besides the reciprocal transcriptional changes of key factors, distinct transcriptional mechanisms may underlie upscaling and downscaling. Our data therefore provide a resource to begin an exploration of such distinct molecular machineries.</p>
<p id="p0150">Several lines of evidence support a model in which RAI1 acts to constrain synaptic upscaling in networks with baseline levels of activity by preventing premature transcriptional responses normally driven by altered network activity (<xref ref-type="fig" rid="fig7">Figure 7</xref>
). First, RAI1 deficiency shifts gene expression toward TTX-associated transcriptional states (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Second, RAI1 occupies its target promoters strongly in the resting cells and dissociates when network activity shifts (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Third, <italic>Rai1</italic> KD led to an increase in excitatory synaptic strength, reflected by enhanced mEPSC amplitudes and associated with an increase in network firing rate (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Our data further indicate the additional role of RAI1 in promoting synaptic upscaling when the network experiences prolonged activity depression (<xref ref-type="fig" rid="fig6">Figure 6</xref>). This latter role of RAI1 again involves direct control of TTX-induced transcriptional responses (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>). The most remarkable aspect of these observations might be the predictive capability of BrU-seq results for RAI1’s roles in chromatin regulation and synaptic plasticity.<fig id="fig7"><label>Figure 7</label><caption><p>RAI1’s Role as a State-Dependent Transcriptional Regulator of TTX-Response Genes</p><p>RAI1 alters synaptic efficacy through activity-dependent chromatin binding and plays essential roles in regulating TTX-response genes under baseline and activity-suppressed states.</p></caption><graphic xlink:href="gr7_lrg"></graphic></fig></p>
<p id="p0155">The present work provides insights into RAI1-mediated regulation of gene transcription. RAI1 is a nucleosome-binding protein and is thought to act as a transcriptional coactivator (<xref ref-type="bibr" rid="bib7">Bi et al., 2005</xref>). Our data demonstrate that RAI1 can also repress transcription depending on the target genes (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We could not identify genomic features that separate coactivator and corepressor functions (not shown), but other studies suggest some possibilities. Like RAI1, TET3 and EHMT1/2 have important roles in homeostatic upscaling (<xref ref-type="bibr" rid="bib4">Benevento et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>). While TET3 positively regulates transcription by removing CpG methylation (<xref ref-type="bibr" rid="bib33">Ito et al., 2010</xref>), EHMT1/2 generally acts as a transcriptional repressor by placing the repressive histone H3K9 methylation mark (<xref ref-type="bibr" rid="bib57">Tachibana et al., 2005</xref>). Thus, the two facets of RAI1’s role in transcriptional dynamics could be through interactions with positive and negative transcriptional regulators, such as TET3 and EHMT1/2.</p>
<p id="p0160">It is noteworthy that all the four previously characterized chromatin regulators in synaptic scaling (i.e., TET3, EHMT1/2, and L3MBTL1) were chosen for investigations, because network activity alters their expression or target histone modifications (<xref ref-type="bibr" rid="bib4">Benevento et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Mao et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>). We found no indication that neuronal activity influences RAI1 expression (<xref ref-type="supplementary-material" rid="mmc1">Figures S2</xref>A and S5B). These observations suggest that chromatin regulators linked to human cognitive disorders could participate in synaptic scaling and other forms of transcription-dependent plasticity, even when their expression remains stable during the process. The predominant chromatin occupancy by RAI1 during stable periods of network activity (<xref ref-type="fig" rid="fig5">Figure 5</xref>) is unique among the scaling-associated chromatin factors, which all appear to be activated by network activity alterations. Post-translational modifications on RAI1 itself or chromatin are potential mechanisms for the RAI1 dissociation from chromatin. Thus, RAI1 offers a molecular mechanism that stabilizes network activity, and future investigations may uncover a similar mode of action in other chromatin regulators associated with human cognitive deficits.</p>
<p id="p0165">How do RAI1’s roles in synaptic scaling relate to cognitive function? Thorough characterization of cell type-specific <italic>Rai1</italic>-KO mice attributed their learning deficits to GABAergic interneurons rather than glutamatergic excitatory neurons (<xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>). Because we measured mEPSCs in the pyramidal cells that incorporated the sparsely transfected <italic>Rai1</italic>-shRNA plasmid, RAI1’s role in synaptic scaling is cell autonomous to excitatory neurons. The lack of learning deficits in forebrain-specific <italic>Rai1</italic>-KO (<italic>Emx1</italic>-Cre: <italic>Rai1</italic>
<sup>flox/flox</sup>) may suggest that impaired cognitive function is independent of RAI1’s role in synaptic scaling. Alternatively, unknown genes may compensate for synaptic scaling deficits during development thus obscuring the contribution of RAI1 in excitatory neurons that can only be seen in acute RAI1 deficiency. Of note, a recent study reported reduced dendritic spine density in the prefrontal cortex of 4-week-old <italic>Rai1</italic>-heterozygous mice (<xref ref-type="bibr" rid="bib30">Huang et al., 2018</xref>), which are genetically similar to SMS patients. The spine deficits in <italic>Rai1</italic>-heterozygous mice may relate to RAI1’s role in synaptic upscaling identified here. Identifying RAI1-target genes that mediate the synaptic phenotype will illuminate the molecular pathways underlying the cell-autonomous roles of RAI1.</p>
<p id="p0170">A limitation of the BrU-seq approach is the lack of cell type specificity. Recently, <xref ref-type="bibr" rid="bib67">Zajaczkowski et al. (2018)</xref> reported nascent RNA-seq specifically in neurons. They used <italic>Synapsin I</italic> promoter-driven expression of uracil phosphoribosyltransferase (UPRT) to label RNAs of neurons. The UPRT system identified more than 3,000 depolarization-regulated genes over the 3 h KCl treatments, which likely detected both nascent transcripts and steady-state mRNAs. Cell type specificity of the UPRT system comes with the cost of introducing the UPRT transgene and additional experimental steps to label RNAs. Furthermore, single-cell RNA-seq of <italic>Rai1</italic>-KD neurons might illuminate cell type-specific roles for RAI1. Single-cell RNA-seq, however, mostly characterizes poly(A)-selected steady-state mRNAs. Thus, it will be important to choose the most suitable experimental approach for RNA profiling depending on specific goals of the study.</p>
<p id="p0175">Our RAI1 ChIP-seq study involves a single replicate because of the unexpected and sustained laboratory closures during the ongoing coronavirus disease 2019 (COVID-19) pandemic. When laboratory operations resume, we plan to collect data of a second replicate and share the data via the GEO database. Our ChIP-seq data, nonetheless, include robust controls (i.e., <italic>Rai1</italic>-KD samples and internal spike-in controls); therefore, it is unlikely that the conclusion will change with new datasets.</p>
<p id="p0180">In summary, our results indicate that nascent RNA-seq with BrU-seq uncovers robust and dynamic transcriptional responses during alterations in network activity. Transcriptional changes are largely unique in response to network hyperactivation or suppression, rather than reciprocal. Our studies further identify a unique role for RAI1 in homeostatic synaptic plasticity, whereby during stable patterns of activity, it suppresses a transcriptional program engaged during activity suppression. These findings illuminate principles whereby dysregulated chromatin signaling may contribute to neurodevelopmental disorders.</p>
</sec>
</sec>
<sec id="sec3">
<title>STAR★Methods</title>
<sec id="sec4.1">
<title>Key Resources Table</title>
<p id="p0190">
<table-wrap id="undtbl1" position="float"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>anti-BrdU antibody</td><td>Santa Cruz Biotechnology</td><td>Cat. No. sc-32323; RRID: <ext-link ext-link-type="uri" id="interref60" xlink:href="nif-antibody:AB_626766">AB_626766</ext-link></td></tr><tr><td>anti-PCNA antibody</td><td>Santa Cruz Biotechnology</td><td>Cat. No. sc-56; RRID: <ext-link ext-link-type="uri" id="interref65" xlink:href="nif-antibody:AB_628110">AB_628110</ext-link></td></tr><tr><td>anti-beta-actin antibody</td><td>Sigma</td><td>Cat. No. A5441; RRID: <ext-link ext-link-type="uri" id="interref70" xlink:href="nif-antibody:AB_476744">AB_476744</ext-link></td></tr><tr><td>HRP-conjugated secondary anti-IGG antibody</td><td>EMD Millipore</td><td>Cat. No. AP132P/Cat. No. AQ160P; RRID: <ext-link ext-link-type="uri" id="interref80" xlink:href="nif-antibody:AB_90264">AB_90264</ext-link>; RRID: <ext-link ext-link-type="uri" id="interref75" xlink:href="nif-antibody:AB_92795">AB_92795</ext-link></td></tr><tr><td>anti-NeuN</td><td>EMD Millipore</td><td>Cat. No. MAB377; RRID: <ext-link ext-link-type="uri" id="interref85" xlink:href="nif-antibody:AB_2298772">AB_2298772</ext-link></td></tr><tr><td>anti-GFAP</td><td>NeuroMab</td><td>Cat. No. N206A/8; RRID: <ext-link ext-link-type="uri" id="interref90" xlink:href="nif-antibody:AB_10672298">AB_10672298</ext-link></td></tr><tr><td>anti-MAP2</td><td>EMD Millipore</td><td>Cat. No. AB5543; RRID: <ext-link ext-link-type="uri" id="interref95" xlink:href="nif-antibody:AB_571049">AB_571049</ext-link></td></tr><tr><td>anti-OLIG2</td><td>EMD Millipore</td><td>Cat. No. AB9610; RRID: <ext-link ext-link-type="uri" id="interref100" xlink:href="nif-antibody:AB_570666">AB_570666</ext-link></td></tr><tr><td>anti-CD11b</td><td>Abcam</td><td>Cat. No. ab133357; RRID: <ext-link ext-link-type="uri" id="interref105" xlink:href="nif-antibody:AB_2650514">AB_2650514</ext-link></td></tr><tr><td>anti-GAD67</td><td>Santa Cruz</td><td>Cat. No. sc-5602; RRID: <ext-link ext-link-type="uri" id="interref110" xlink:href="nif-antibody:AB_2107748">AB_2107748</ext-link></td></tr><tr><td>anti-GluA1</td><td>EMD Millipore</td><td>Cat. No. ABN241; RRID: <ext-link ext-link-type="uri" id="interref115" xlink:href="nif-antibody:AB_2721164">AB_2721164</ext-link></td></tr><tr><td>anti-PSD95</td><td>EMD Millipore</td><td>Cat. No. MAB1596; RRID: <ext-link ext-link-type="uri" id="interref120" xlink:href="nif-antibody:AB_2092365">AB_2092365</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Bacterial and Virus Strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>pMD.2G plasmid for lentiviral production</td><td>AddGene</td><td>Plasmid #12259; RRID: Addgene_12259</td></tr><tr><td>psPAX2 plasmid for lentiviral production</td><td>AddGene</td><td>Plasmid #12260; RRID: Addgene_12260</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, Peptides, and Recombinant Proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>5-Bromouridine</td><td>Sigma</td><td>Cat. No. 18670</td></tr><tr><td>bicuculline-methiodide</td><td>Abcam</td><td>Cat. No. ab120108</td></tr><tr><td>Tri-Reagent BD</td><td>Sigma</td><td>Cat. No. T3809</td></tr><tr><td>DNase I</td><td>New England Biolabs</td><td>Cat. No. M0303</td></tr><tr><td>RNA ligase 1</td><td>New England Biolabs</td><td>Cat. No. M0437</td></tr><tr><td>truncated RNA ligase KQ</td><td>New England Biolabs</td><td>Cat. No. M0373</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Deposited Data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RAI1 Bru-seq/ChIP-seq data</td><td>Gene Expression Omnibus</td><td>GEO: <ext-link ext-link-type="uri" id="interref125" xlink:href="ncbi-geo:GSE121749">GSE121749</ext-link></td></tr><tr><td>DNase-Hypersensitivity sites, Mouse brain E14.5</td><td><xref ref-type="bibr" rid="bib61">Vierstra et al. (2014)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref130" xlink:href="ncbi-geo:GSM1014197">GSM1014197</ext-link></td></tr><tr><td>DNase-Hypersensitivity sites, Mouse brain 8 week adult</td><td><xref ref-type="bibr" rid="bib61">Vierstra et al. (2014)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref135" xlink:href="ncbi-geo:GSM1014151">GSM1014151</ext-link></td></tr><tr><td>H3K4me1 ChIp-seq, mouse brain, 8 week</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref140" xlink:href="ncbi-geo:GSM769022">GSM769022</ext-link></td></tr><tr><td>H3K4me1 ChIp-seq, mouse brain, E14.5</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref145" xlink:href="ncbi-geo:GSM1000096">GSM1000096</ext-link></td></tr><tr><td>H3K4me3 ChIP-seq, mouse brain, 8 week</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref150" xlink:href="ncbi-geo:GSM769026">GSM769026</ext-link></td></tr><tr><td>H3K4me3 ChIP-seq, mouse brain, E14.5</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref155" xlink:href="ncbi-geo:GSM1000095">GSM1000095</ext-link></td></tr><tr><td>H3K27ac ChIP-seq mouse brain, E14.5</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref160" xlink:href="ncbi-geo:GSM1000094">GSM1000094</ext-link></td></tr><tr><td>H3K27ac ChIP-seq mouse brain 8 week</td><td><xref ref-type="bibr" rid="bib10">Boxer et al. (2020)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref165" xlink:href="ncbi-geo:GSM3666438">GSM3666438</ext-link></td></tr><tr><td>H3K27me2 ChIP-seq mouse brain E14.5</td><td><xref ref-type="bibr" rid="bib20">ENCODE Project Consortium (2012)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref170" xlink:href="ncbi-geo:GSM1000143">GSM1000143</ext-link></td></tr><tr><td>H3K27me3 ChIP-seq mouse brain, 8 week</td><td><xref ref-type="bibr" rid="bib10">Boxer et al. (2020)</xref></td><td>GEO: <ext-link ext-link-type="uri" id="interref175" xlink:href="ncbi-geo:GSM3666437">GSM3666437</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Experimental Models: Organisms/Strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Mouse:CD-1</td><td>Charles River</td><td>Strain 022</td></tr><tr><td>Rat:Sprague-Dawley</td><td>Charles River</td><td>Strain 001</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Oligonucleotides</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RNA-sequencing library preparation primers</td><td>See <xref ref-type="supplementary-material" rid="mmc1">Table S6</xref> for primers used</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Recombinant DNA</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>full-length human RAI1 cDNA</td><td>reverse transcription from human cell lines</td><td>GenBank: NM_030665.3</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and Algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Bowtie1</td><td><xref ref-type="bibr" rid="bib39">Langmead et al. (2009)</xref></td><td>N/A</td></tr><tr><td>Bowtie2</td><td><xref ref-type="bibr" rid="bib38">Langmead and Salzberg (2012)</xref></td><td>N/A</td></tr><tr><td>We used MACS2</td><td><xref ref-type="bibr" rid="bib68">Zhang et al. (2008)</xref></td><td>version 2.1.0.20140616</td></tr><tr><td>DESeq2</td><td><xref ref-type="bibr" rid="bib42">Love et al. (2014)</xref></td><td>N/A</td></tr><tr><td>Tophat2</td><td><xref ref-type="bibr" rid="bib36">Kim et al. (2013)</xref></td><td>N/A</td></tr><tr><td>LRPath/RNAEnrich</td><td><xref ref-type="bibr" rid="bib35">Kim et al. (2012)</xref></td><td>N/A</td></tr><tr><td>Custom MEA analysis</td><td><ext-link ext-link-type="uri" id="intref0020" xlink:href="https://github.com/Jcrd25/NeuroMEACode">https://github.com/Jcrd25/NeuroMEACode</ext-link></td><td>N/A</td></tr></tbody></table></table-wrap>
</p>
</sec>
<sec id="sec4.2">
<title>Resource Availability</title>
<sec id="sec4.2.1">
<title>Lead Contact</title>
<p id="p0195">Further information and requests for resources and reagents should be directed to and will be fulfilled by Shigeki Iwase (<ext-link ext-link-type="uri" id="intref0025" xlink:href="mailto:siwase@umich.edu">siwase@umich.edu</ext-link>)</p>
</sec>
<sec id="sec4.2.2">
<title>Materials Availability</title>
<p id="p0200">There are restrictions to the availability of the custom RAI1 antibody due to limited supply.</p>
</sec>
<sec id="sec4.2.3" sec-type="data-availability">
<title>Data and Code Availability</title>
<p id="p0205">Sequencing data generated for this study have been submitted to the NCBI Gene Expression Omnibus (GEO; <ext-link ext-link-type="uri" id="intref0030" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) under accession number <ext-link ext-link-type="uri" id="intref0035" xlink:href="ncbi-geo:GSE121749">GSE121749</ext-link>.</p>
<p id="p0210">Custom MEA analysis scripts can be found at <ext-link ext-link-type="uri" id="intref0040" xlink:href="https://github.com/Jcrd25/NeuroMEACode">https://github.com/Jcrd25/NeuroMEACode</ext-link>
</p>
</sec>
</sec>
<sec id="sec4.3">
<title>Experimental Model and Subject Details</title>
<sec id="sec4.3.1">
<title>Primary Mouse Forebrain Cultures</title>
<p id="p0215">Cortices and hippocampi from E18.5 CD1 mouse pups (Charles River, Strain 022) were pooled into biological replicates with identical female:male ratios. Sex of the pups was determined by PCR using primers for the ZFY gene (<xref ref-type="supplementary-material" rid="mmc1">Table S6</xref>). Primary culture of neurons was carried out as previously described (<xref ref-type="bibr" rid="bib34">Iwase et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Vallianatos et al., 2018</xref>). Briefly, dissociated tissues were plated at 4 million cells/6 cm poly-D-lysine-coated plate (Sigma) grown in Neurobasal Media supplemented with B27 (GIBCO, #17504044). No mitotic inhibitors or antibiotics were added. Half the culture medium was freshened every 3-5 days.</p>
</sec>
<sec id="sec4.3.2">
<title>Primary Rat Hippocampal Cultures</title>
<p id="p0220">All animal use followed NIH guidelines and was in compliance with the University of Michigan Committee on Use and Care of Animals. Dissociated postnatal (P0-3) hippocampal neuron cultures were prepared from Sprague-Dawley rats (Charles River, Strain 001) as previously described (<xref ref-type="bibr" rid="bib71">Henry et al., 2012</xref>). Sex of rat pups was not determined. For MEA experiments, neurons were plated onto sterile multi-electrode arrays chips (MEAs) (60MEA200/30IR–TI; Multichannel Systems, Reutlingen, Germany) at a density of ∼350 cells/mm2. MEAs were coated with 0.05% polyethyleneimine and laminin (1 ug/ul). MEAs were transferred to the incubator for &gt; 3 h to allow for cell adhesion. Media was composed of Neurobasal Plus Medium with 1X B-27 Plus supplement, 1X GlutaMax and 50 U/ml of Pen/Strep (ThermoFisher, Waltham, MA). MEAs were covered with a gas permeable ethlylene propylene membrane (MEA-MEM, Multichannel Systems, Reutlingen, Germany). Half-volume media exchanges were done every 3-4 days. Cultures that exhibited spontaneous spiking activity on ≥ 10 electrodes on DIV10 were considered healthy and included in the study.</p>
</sec>
</sec>
<sec id="sec4.4">
<title>Method Details</title>
<sec id="sec4.4.1">
<title>Lentivirus preparation</title>
<p id="p0225">Lentivirus were generated using co-transfection into HEK293t cells of psPAX2 (Addgene, 12260), pMD2.G (AddGene, 12259) and pLKO plasmids containing shRNA against <italic>Rai1</italic> untranslated region (<italic>Rai1</italic>-shRNA #1: Sigma, TRCN0000124984) or coding region (<italic>Rai1</italic>-shRNA #2: Sigma, TRCN0000328334) or scramble shRNA (Sigma, SHC202). For Bru-seq and ChIP-seq experiments, we used SHC202 and <italic>Rai1</italic>-shRNA #1. For electrophysiology, we used SHC202, <italic>Rai1</italic>-shRNA #1 and #2, whose target sequences are identical between mouse and rat. The conditioned media containing lentiviruses was collected, concentrated with Lenti-X concentrator (Takara, 631232), and resuspended in Neurobasal medium, and stored at −80°C. The titer of lentivirus was determined by survival of transduced 293 cells under puromycin and a comparable amount of virus that result in &gt;90% survival of infected neurons was used for all biological replicates.</p>
</sec>
<sec id="sec4.4.2">
<title>Activity Alteration and Bru-seq</title>
<p id="p0230">On DIV14, cells were infected with lentiviral shRNA as previously described (<xref ref-type="bibr" rid="bib60">Vallianatos et al., 2018</xref>). On DIV17, cells were treated with bicuculline-methiodide (Abcam, ab120108, 20 μM), TTX (Tocris, 1069, 1 μM), or vehicle (sterile water), for 4 h. 3 h, and 40 min post treatment, bromouridine (Bru, Sigma, 18670, dissolved in PBS) was added to cultures at 2 mM final concentration. Cultures were harvested in Tri-reagent BD (Sigma, T3809) and frozen immediately. RNA was purified using phenol-chloroform extraction and isopropaonol precipitation, treated with DNase-I (NEB, M0303) then fragmented by high-magnesium, high temperature incubation. From 1 μg of total RNA, enrichment of Bru-containing RNA and library preparation were performed as previously described (<xref ref-type="bibr" rid="bib48">Paulsen et al., 2013</xref>, <xref ref-type="bibr" rid="bib49">2014</xref>) with minor modifications. We designed custom adaptors (<xref ref-type="supplementary-material" rid="mmc1">Table S6</xref>) which were directly ligated to the 3′ ends of RNA using RNA ligase 1 (NEB Cat. No. M0437) and truncated RNA ligase KQ (NEB M0373). Bromouridine-labeled RNAs were immunoprecipitated using anti-BrdU antibody (Santa Cruz Biotechnology, sc-32323). Enriched RNAs were reverse transcribed using a primer complementary to the RNA adaptor (<xref ref-type="supplementary-material" rid="mmc1">Table S6</xref>). Adaptor duplexes with 5- or 6-base pair random nucleotide overhangs were ligated to the 3′ end of the cDNA (<xref ref-type="supplementary-material" rid="mmc1">Table S6</xref>). The cDNA libraries were amplified using primers that carry Illumina indices, then 180-400 bp DNA fragments were isolated using by an agarose gel. The nucleotide sequences of primers used for library amplification are found in <xref ref-type="supplementary-material" rid="mmc1">Table S6</xref>. The libraries were subjected to single-end 50-bp sequencing using IIlumina HiSeq 2000 platform.We performed 2 to 3 biological replicates for all drug treatment and knockdown conditions.</p>
</sec>
<sec id="sec4.4.3">
<title>ChIP-seq</title>
<p id="p0235">ChIP was performed as previously described (<xref ref-type="bibr" rid="bib34">Iwase et al., 2016</xref>). We dissociated E18 mouse forebrains and culture them for 14 DIV, infected with lentivirus containing sh-<italic>Rai1</italic> #1 or sh-Ctrl. On DIV17, we treated cultures with 2 μM TTX, 20 μM BIC, or water vehicle for 4 h, harvested the cells, fixed with 1% formaldehyde in HBSS for 30 min at room temperature, and prepared chromatin samples. We digested chromatin first with MNase for 20 min at 25°C. We then spiked, <italic>Drosophila</italic> chromatin, which contains fly-specific histone variant H2Av (Active Motif Cat. No. 53083). Samples were then further sheared by sonication using Qsonica Q800R3 at 70% amplitude 15 s pulse with 20 s interval for 30 min (total time: 70 min). The antibodies applied were the abovementioned anti-RAI1 polyclonal and anti-<italic>Drosophila</italic> H2Av antibodies (2.5 μg/sample). Antibody-antigen complex that formed at 4°C overnight were precipitated with Dynabeads Protein A/G mixture (1:1, Invitrogen 10001D, 10003D). We isolated the pulled down DNA and made sequencing libraries with NEBNext reagents (E7645S) and sequenced them on the Illumina HiSeq4000 platform to generate 50 bp single-end reads.</p>
</sec>
<sec id="sec4.4.4">
<title>Patch-Clamp Electrophysiology</title>
<p id="p0240">Neurons were transfected with 1.0 μg of either sh-Ctrlor sh-<italic>Rai1</italic> #1 or #2. For the rescue experiments, an RNAi-resistant RAI1-expression plasmid or its empty vector were co-transfected with the above shRNA expressing plasmids. Transfections were performed using CalPhos Transfection kit (ClonTech) or Lipofectamine 2000 (ThermoFisher Scientific) according to the manufacturer’s protocols. All experiments were performed 48 h after transfection. To induce synaptic scaling, neurons were treated with either 1 μM TTX, 10 μM bicuculine or vehicle for 24hr prior to recording. mEPSCs were recorded from a holding potential of – 70 mV with an Axopatch 200B or Multiclamp 700B amplifier from neurons bathed in HEPES buffered saline (HBS) containing: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 mM HEPES (pH 7.4) plus 1 μM TTX and 10 μM bicuculline.</p>
</sec>
<sec id="sec4.4.5">
<title>Multi-Electrode Array Electrophysiology</title>
<p id="p0245">On DIV11, neurons were transfected with lentivirus encoding sh-Ctrl or sh-<italic>Rai1</italic> #1 or #2 by performing a half-media change. On DIV14, Local Field Potential (LFP) recordings were acquired at 20 kHz using a MEA2100-System (Multichannel Systems, Reutlingen, Germany). MEA chips were secured to the headstage of the amplifier and maintained in a controlled environment (37°C, 5% CO2) for the duration of the recording. Prior to recording, MEAs were undisturbed for eight min to allow for acclimation after handling.</p>
</sec>
<sec id="sec4.4.6">
<title>Immunofluorescence</title>
<p id="p0250">Surface GluA1 staining was conducted as previously described with slight modification (<xref ref-type="bibr" rid="bib71">Henry et al., 2012</xref>). On DIV12, rat cultured hippocampal cells were infected either with lentivirus carrying sh-Ctrl or sh-<italic>Rai1</italic> as described above. After 72 h of incubation, cultured cells were live-labeled with rabbit anti-GluA1 antibody (10 μg/ml, EMD Millipore, ABN241) for 20 min at 37°C, fixed with 2% paraformaldehyde, and further labeled with mouse anti-PSD-95 (EMD Millipore, MAB1596, 1:1000). Goat anti-mouse Alexa 488 and Goat anti-rabbit Alexa 555 secondary antibodies (Abcam, 1:500) were applied for 60 min at room temperature to visualize PSD-95 and GluA1 staining. Images of PSD-95 and GluA1 were acquired blinded tocondition using an inverted Olympus FV1000 laser-scanning confocal microscope using a Plan-Apochromat 63 X /1.4 oil objective.</p>
<p id="p0255">For RAI1 and cell-type marker staining, two biological replicates of forebrain neuron cultures were obtained from E17.5 mouse embryos. On DIV19, they were fixed with 4% paraformaldehyde in 16% sucrose/PBS, permeabilized with 0.25% Triton-X in 1X PBS, blocked for 30 min with 10% bovine albumin serum (Sigma A2153), and overnight incubation of antibodies in 3% BSA at 4°C.Primary antibodies used in the study are following. anti-NeuN (EMD Millipore, MAB377, 1:1000), anti-GFAP (NeuroMab N206A/8, 1:1000), anti-MAP2 (EMD Millipore, AB5543, 1:1000), anti-OLIG2 (EMD Millipore, AB9610, 1:1000), anti-CD11b (Abcam, ab133357, 1:500), anti-GAD67 (Santa Cruz, sc-5602, 1:1000). Secondary antibodies (Invitrogen Alexa Fluor 488, 555, or 647) were applied for 45 min at room temperature. Fluorescence images were acquired blinded to condition using an Olympus BX61 fluorescence microscope (60X oil-immersion lens) and CellSense software.</p>
</sec>
<sec id="sec4.4.7">
<title>Western Blot</title>
<p id="p0260">To validate <italic>Rai1</italic>-KD in mouse forebrain neuron culture, <italic>Rai1</italic>-KD and control cultures were harvested at 3 days after lentiviral transduction and subjected to western blot analysis as described previously (<xref ref-type="bibr" rid="bib34">Iwase et al., 2016</xref>). RAI1 antibodies were generated by immunizing rabbits with a synthesized RAI1 peptide (aa 28 to 42, ENYRQPGQAGLSCDR, Thermo Fisher Scientific), followed by affinity purification using the peptide as the affinity ligand (Thermo Fisher Scientific). Anti-PCNA antibody (Santa Cruz sc-56, 1:1000) was used for a loading control. For analysis of RAI1 level during activity shifts, the cortices from E18.5 rat pups were dissected, dissociated, and plated at 700,000 cells/well in a PDL-coated 6-well dish. Neurons were grown in Neurobasal/B27 medium for 14 DIV. Vehicle (1% water), TTX (1 μM) or BIC (20 μM) were added to the culture and cells were harvested with a 1:1 mixture of 2X Laemmeli buffer (BioRad, 1610737, 1:20 beta-mercaptoethanol) and radioimmunoprecipitation assay (RIPA) buffer supplemented with 50 mM BGP and 1 mM Na3VO4. Protein samples were boiled for 10 min at 100°C. 10-15 μg of each sample was loaded per lane, separated by 7.5% SDS-PAGE, and transferred onto PVDF membrane (Millipore IPVH00010). Membranes were then blocked with 5% skim milk or 3% blotting-grade blocker (BioRad 1706404) for 1 hr, probed overnight with the following primary antibodies diluted in 3% BSA (Fisher Scientific BP1600): RAI1 (1:1000), beta-actin (Sigma A5441, 1:20,000). Horseradish peroxide (HRP)-conjugated secondary IgG antibodies (EMD Millipore AP132P or AQ160P) were also diluted in 3% BSA, and the HRP signal was developed with various chemiluminescent substrates from Thermo Fisher Scientific (34080 or 34095) and Li-COR Biosciences (926-95000).</p>
</sec>
</sec>
<sec id="sec4.5">
<title>Quantification and Statistical Analysis</title>
<sec id="sec4.5.1">
<title>Bru-seq Activity-Induction</title>
<p id="p0265">After confirming the quality of sequencing data by FastQC, reads were mapped to mm9 reference genome using Bowtie2 (<xref ref-type="bibr" rid="bib38">Langmead and Salzberg, 2012</xref>) and annotated with Tophat2 (<xref ref-type="bibr" rid="bib36">Kim et al., 2013</xref>). Adaptors were trimmed using BBDUK (<ext-link ext-link-type="uri" id="intref0045" xlink:href="https://jgi.doe.gov/data-and-tools/bb-tools/">https://jgi.doe.gov/data-and-tools/bb-tools/</ext-link>), when 2-30 bp on the left of the read matched the predicted adaptor (k = 30, mink = 2, minlength = 15, hdist = 1). Bru-seq signals were quantified by FeatureCounts (<xref ref-type="bibr" rid="bib41">Liao et al., 2014</xref>). We excluded <italic>Rn45s</italic>, <italic>Lars2</italic>, <italic>Rn4.5 s</italic>, <italic>Cdk8</italic>, <italic>Zc3h7a</italic> and the mitochondrial chromosome to avoid counts of overamplified genes that may skew RPKM normalization. DE-genes were identified using DESeq2 (<xref ref-type="bibr" rid="bib42">Love et al., 2014</xref>) using the same parameters for the Bru-seq data and three published mRNA-seq datasets of neuron culture and <italic>Rai1</italic>-KO mice (<xref ref-type="bibr" rid="bib29">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib53">Schaukowitch et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Yu et al., 2015b</xref>). We also used DESeq2 to calculate RPKM expression values across the entire genic regions, including introns. Correlation analyses used base R Spearman Rank correlation test coupled with t tests to avoid the effect of extreme outliers (<xref ref-type="fig" rid="fig2">Figures 2</xref>, <xref ref-type="fig" rid="fig4">4</xref> and <xref ref-type="supplementary-material" rid="mmc1">S5</xref>). Fold change comparisons were tested using the non-parametric Wilcoxon rank-sum/Mann-Whitney U test (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig4">4</xref>) Gene ontology was examined using RNA-Enrich (<xref ref-type="bibr" rid="bib40">Lee et al., 2016</xref>). Significance cutoff for reporting Sig-genes was an unadjusted p value &lt; 0.05. We only presented GO terms that contain 5 to 250 genes.</p>
</sec>
<sec id="sec4.5.2">
<title>ChIP-seq</title>
<p id="p0270">Raw reads were demultiplexed and filtered according to the standard Illumina analysis pipeline. Reads from sequencing libraries were then mapped to the mouse (mm9) and fruit fly (dm6) genome assemblies using Bowtie1 (<xref ref-type="bibr" rid="bib39">Langmead et al., 2009</xref>) allowing up to 2 mismatches. Only uniquely-mapped reads were used for analysis. We used MACS2 (version 2.1.0.20140616, FDR &lt; 0.01) to identify RAI1 peaks using pooled input samples as a control (<xref ref-type="bibr" rid="bib68">Zhang et al., 2008</xref>). For visualization in the UCSC browser, bigwig files were generated with coverage normalized using the number of mapped reads to the <italic>Drosophila</italic> genome (reads mapped per reference genome per million reads) (<xref ref-type="bibr" rid="bib18">Egan et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Orlando et al., 2014</xref>). ChIPseeker (<xref ref-type="bibr" rid="bib65">Yu et al., 2015a</xref>) annotated RAI1 peaks to promoters, genic, or intergenic regions. We integrated following publically available epigenomic datasets: DNase I hypersensitive sites (DHS) of whole brain samples (<xref ref-type="bibr" rid="bib61">Vierstra et al., 2014</xref>) (E14.5: GEO: <ext-link ext-link-type="uri" id="interref180" xlink:href="ncbi-geo:GSM1014197">GSM1014197</ext-link>, 8 week adult: GEO: <ext-link ext-link-type="uri" id="interref185" xlink:href="ncbi-geo:GSM1014151">GSM1014151</ext-link>), H3K4me1(<xref ref-type="bibr" rid="bib20">ENCODE Project Consortium, 2012</xref>): whole brain (8 week: GEO: <ext-link ext-link-type="uri" id="interref190" xlink:href="ncbi-geo:GSM769022">GSM769022</ext-link>, E14.5: GEO: <ext-link ext-link-type="uri" id="interref195" xlink:href="ncbi-geo:GSM1000096">GSM1000096</ext-link>), H3K4me3 (<xref ref-type="bibr" rid="bib20">ENCODE Project Consortium, 2012</xref>): whole brain (8 week: GEO: <ext-link ext-link-type="uri" id="interref205" xlink:href="ncbi-geo:GSM769026">GSM769026</ext-link>, E14.5: GEO: <ext-link ext-link-type="uri" id="interref200" xlink:href="ncbi-geo:GSM1000095">GSM1000095</ext-link>): H3K27ac (E14.5 whole brain (<xref ref-type="bibr" rid="bib20">ENCODE Project Consortium, 2012</xref>)): GEO: <ext-link ext-link-type="uri" id="interref210" xlink:href="ncbi-geo:GSM1000094">GSM1000094</ext-link>, 8 week forebrain (<xref ref-type="bibr" rid="bib10">Boxer et al., 2020</xref>): GEO: <ext-link ext-link-type="uri" id="interref215" xlink:href="ncbi-geo:GSM3666438">GSM3666438</ext-link>): and H3K27me (E14.5 H3K27me2 whole-brain (<xref ref-type="bibr" rid="bib20">ENCODE Project Consortium, 2012</xref>): GEO: <ext-link ext-link-type="uri" id="interref225" xlink:href="ncbi-geo:GSM1000143">GSM1000143</ext-link>, 8 week H3K27me3 forebrain (<xref ref-type="bibr" rid="bib10">Boxer et al., 2020</xref>), GEO: <ext-link ext-link-type="uri" id="interref220" xlink:href="ncbi-geo:GSM3666437">GSM3666437</ext-link>). Putative transcriptional enhancers were defined as DHS-positive RAI1 peaks (±500 bp) that overlap with H3K4me1 but not H3K4me3. Correlation analyses used base R Spearman Rank correlation test coupled with t tests to avoid the effect of extreme outliers (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="supplementary-material" rid="mmc1">S5</xref>). Enrichment analysis was tested using Chi-square test (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="supplementary-material" rid="mmc1">S5</xref>)</p>
</sec>
<sec id="sec4.5.3">
<title>Patch-Clamp Electrophysiology</title>
<p id="p0275">Miniature EPSCs were analyzed offline using MiniAnalysis. Statistical differences between experimental conditions were determined by unpaired Student’s t tests (<xref ref-type="fig" rid="fig6">Figure 6</xref>) or one-way ANOVA followed by post hoc Fisher’s LSD test (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
</sec>
<sec id="sec4.5.4">
<title>Multi-Electrode Array Electrophysiology</title>
<p id="p0280">Spontaneous activity was captured during 5 min epochs. Data were imported into MATLAB (MathWorks, Natick, MA) and analyzed using custom written scripts (<ext-link ext-link-type="uri" id="intref0050" xlink:href="https://github.com/Jcrd25/NeuroMEACode">https://github.com/Jcrd25/NeuroMEACode</ext-link>) The LFP signal was high pass filtered at 100 Hz using a Butterworth filter. Spikes were detected using amplitude thresholds set at five times the root mean square of the noise. Neuronal units were identified by spike sporting using principal component analysis of the detected spike and manually identifying clusters. A spike was defined by the signal 1 ms before the peak to 3 ms after the peak. The inter spike interval was defined as the time between two adjacent spikes. Mean firing frequency was calculated by dividing the total number of spikes detected for each neuronal unit by the recording duration. Statistical analyses were done in MATLAB and GraphPad Prism (GraphPad Software, San Diego, CA). Kruskal-Wallis test followed by post hoc Dunn’s multiple comparisons test were performed on data from three biological replicates.</p>
</sec>
<sec id="sec4.5.5">
<title>Immunofluorescence</title>
<p id="p0285">For RAI1 and cell-type marker staining, immunoreactivity was quantified blinded to condition and semi-automatedly using ImageJ after confirming specific staining by visual inspection.</p>
<p id="p0290">For synaptic GluA1 staining, synaptic GluA1 was anlayzed on maximal intensity z-projections. Synaptic GluA1 was defined as a particle that occupied &gt;10% of the PSD-95 positive area, and the average integrated intensity of synapatic GluA1 was calculated using custom-written analyses on ImageJ and MATLAB. Statistical differences between experimental conditions were determined by unpaired Student’s t tests.</p>
</sec>
<sec id="sec4.5.6">
<title>Western blot</title>
<p id="p0295">Protein band intensity was visualized and quantified in the linear range using LI-COR C-Digit and Image Studio software. Three biological replicates were used. Results were compared using one-way ANOVA with Dunnett’s test.</p>
</sec>
</sec>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbott</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Synaptic plasticity: taming the beast</article-title>
<source/>Nat. Neurosci.
          <volume>3</volume>
<issue>Suppl</issue>
<year>2000</year>
<fpage>1178</fpage>
<lpage>1183</lpage>
<pub-id pub-id-type="pmid">11127835</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bateup</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Denefrio</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Saulnier</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kornacker</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis</article-title>
<source/>Neuron
          <volume>78</volume>
<year>2013</year>
<fpage>510</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">23664616</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benevento</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iacono</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Selten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lewerissa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kleefstra</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Histone methylation by the Kleefstra syndrome protein EHMT1 mediates homeostatic synaptic scaling</article-title>
<source/>Neuron
          <volume>91</volume>
<year>2016</year>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">27373831</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benito</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barco</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The neuronal activity-driven transcriptome</article-title>
<source/>Mol. Neurobiol.
          <volume>51</volume>
<year>2015</year>
<fpage>1071</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="pmid">24935719</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Saifi</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Walz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome</article-title>
<source/>Hum. Genet.
          <volume>115</volume>
<year>2004</year>
<fpage>515</fpage>
<lpage>524</lpage>
<pub-id pub-id-type="pmid">15565467</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ohyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Visvanathan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Justice</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome</article-title>
<source/>Hum. Mol. Genet.
          <volume>14</volume>
<year>2005</year>
<fpage>983</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="pmid">15746153</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuva-Paylor</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Antalffy</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes</article-title>
<source/>Hum. Mol. Genet.
          <volume>16</volume>
<year>2007</year>
<fpage>1802</fpage>
<lpage>1813</lpage>
<pub-id pub-id-type="pmid">17517686</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgeron</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>
<source/>Nat. Rev. Neurosci.
          <volume>16</volume>
<year>2015</year>
<fpage>551</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="pmid">26289574</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boxer</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Renthal</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Greben</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Whitwam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Silberfeld</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stroud</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Kinde</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>MeCP2 Represses the rate of transcriptional initiation of highly methylated long genes</article-title>
<source/>Mol. Cell
          <volume>77</volume>
<year>2020</year>
<fpage>294</fpage>
<lpage>309.e9</lpage>
<pub-id pub-id-type="pmid">31784358</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brakeman</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Lanahan</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>P.F.</given-names>
</name>
</person-group>
<article-title>Homer: a protein that selectively binds metabotropic glutamate receptors</article-title>
<source/>Nature
          <volume>386</volume>
<year>1997</year>
<fpage>284</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="pmid">9069287</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bramham</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Guzowski</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>The immediate early gene arc/arg3.1: regulation, mechanisms, and function</article-title>
<source/>J. Neurosci.
          <volume>28</volume>
<year>2008</year>
<fpage>11760</fpage>
<lpage>11767</lpage>
<pub-id pub-id-type="pmid">19005037</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>How the epigenome integrates information and reshapes the synapse</article-title>
<source/>Nat. Rev. Neurosci.
          <volume>20</volume>
<year>2019</year>
<fpage>133</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">30696992</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creyghton</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Welstead</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Kooistra</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Carey</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Steine</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lodato</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Frampton</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>107</volume>
<year>2010</year>
<fpage>21931</fpage>
<lpage>21936</lpage>
<pub-id pub-id-type="pmid">21106759</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darvekar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnsen</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Eriksen</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sjøttem</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Identification of two independent nucleosome-binding domains in the transcriptional co-activator SPBP</article-title>
<source/>Biochem. J.
          <volume>442</volume>
<year>2012</year>
<fpage>65</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">22081970</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darvekar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rekdal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sjøttem</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules</article-title>
<source/>PLoS ONE
          <volume>8</volume>
<year>2013</year>
<fpage>e78907</fpage>
<pub-id pub-id-type="pmid">24205348</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebert</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Activity-dependent neuronal signalling and autism spectrum disorder</article-title>
<source/>Nature
          <volume>493</volume>
<year>2013</year>
<fpage>327</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="pmid">23325215</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Craske</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Labhart</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guler</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Arnott</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Maile</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Busby</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>T.K.</given-names>
</name>
</person-group>
<article-title>An alternative approach to ChIP-seq normalization enables detection of genome-wide changes in histone H3 lysine 27 trimethylation upon EZH2 inhibition</article-title>
<source/>PLoS ONE
          <volume>11</volume>
<year>2016</year>
<fpage>e0166438</fpage>
<pub-id pub-id-type="pmid">27875550</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsea</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways</article-title>
<source/>Expert Rev. Mol. Med.
          <volume>13</volume>
<year>2011</year>
<fpage>e14</fpage>
<pub-id pub-id-type="pmid">21545756</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<collab>ENCODE Project Consortium</collab>
</person-group>
<article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
<source/>Nature
          <volume>489</volume>
<year>2012</year>
<fpage>57</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">22955616</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Mechanisms of homeostatic plasticity in the excitatory synapse</article-title>
<source/>J. Neurochem.
          <volume>139</volume>
<year>2016</year>
<fpage>973</fpage>
<lpage>996</lpage>
<pub-id pub-id-type="pmid">27241695</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fragoso</surname>
<given-names>Y.D.</given-names>
</name>
<name>
<surname>Stoney</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Shearer</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Sementilli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nanescu</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Sementilli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McCaffery</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Expression in the human brain of retinoic acid induced 1, a protein associated with neurobehavioural disorders</article-title>
<source/>Brain Struct. Funct.
          <volume>220</volume>
<year>2014</year>
<fpage>1195</fpage>
<lpage>1203</lpage>
<pub-id pub-id-type="pmid">24519454</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Elsas</surname>
<given-names>L.J.</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Devriendt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions</article-title>
<source/>J. Med. Genet.
          <volume>42</volume>
<year>2005</year>
<fpage>820</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="pmid">15788730</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heumüller</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schuman</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>mRNA transport &amp; local translation in neurons</article-title>
<source/>Curr. Opin. Neurobiol.
          <volume>45</volume>
<year>2017</year>
<fpage>169</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">28633045</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzman-Karlsson</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Meadows</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Gavin</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Hablitz</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Transcriptional and epigenetic regulation of Hebbian and non-Hebbian plasticity</article-title>
<source/>Neuropharmacology
          <volume>80</volume>
<year>2014</year>
<fpage>3</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">24418102</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dando</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Jiwaji</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Márkus</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>McQueen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hampton</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Torvell</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism</article-title>
<source/>Nat. Commun.
          <volume>8</volume>
<year>2017</year>
<fpage>15132</fpage>
<pub-id pub-id-type="pmid">28462931</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>McCartney</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Neely</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Carruthers</surname>
<given-names>C.J.L.</given-names>
</name>
<name>
<surname>Stuenkel</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Inoki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Retrograde changes in presynaptic function driven by dendritic mTORC1</article-title>
<source/>J. Neurosci.
          <volume>32</volume>
<year>2012</year>
<fpage>17128</fpage>
<lpage>17142</lpage>
<pub-id pub-id-type="pmid">23197706</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermey</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Blüthgen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kuhl</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Neuronal activity-regulated alternative mRNA splicing</article-title>
<source/>Int. J. Biochem. Cell Biol.
          <volume>91</volume>
<issue>Pt B</issue>
<year>2017</year>
<fpage>184</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">28591617</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hrvatin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hochbaum</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Cicconet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cheadle</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zilionis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ratner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borges-Monroy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex</article-title>
<source/>Nat. Neurosci.
          <volume>21</volume>
<year>2018</year>
<fpage>120</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="pmid">29230054</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Guenthner</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Gozani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Molecular and neural functions of Rai1, the causal gene for Smith-Magenis syndrome</article-title>
<source/>Neuron
          <volume>92</volume>
<year>2016</year>
<fpage>392</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">27693255</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.-H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Klope</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>115</volume>
<year>2018</year>
<fpage>10744</fpage>
<lpage>10749</lpage>
<pub-id pub-id-type="pmid">30275311</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>Rapid synaptic scaling induced by changes in postsynaptic firing</article-title>
<source/>Neuron
          <volume>57</volume>
<year>2008</year>
<fpage>819</fpage>
<lpage>826</lpage>
<pub-id pub-id-type="pmid">18367083</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Igaz</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Vianna</surname>
<given-names>M.R.M.</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Izquierdo</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning</article-title>
<source/>J. Neurosci.
          <volume>22</volume>
<year>2002</year>
<fpage>6781</fpage>
<lpage>6789</lpage>
<pub-id pub-id-type="pmid">12151558</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D’Alessio</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Taranova</surname>
<given-names>O.V.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sowers</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification</article-title>
<source/>Nature
          <volume>466</volume>
<year>2010</year>
<fpage>1129</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="pmid">20639862</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwase</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Badeaux</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vallianatos</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Tomassy</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Kasza</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A mouse model of X-linked intellectual disability associated with impaired removal of histone methylation</article-title>
<source/>Cell Rep.
          <volume>14</volume>
<year>2016</year>
<fpage>1000</fpage>
<lpage>1009</lpage>
<pub-id pub-id-type="pmid">26804915</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Karnovsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahavisno</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Weymouth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pande</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dolinoy</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Rozek</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types</article-title>
<source/>BMC Genomics
          <volume>13</volume>
<year>2012</year>
<fpage>526</fpage>
<pub-id pub-id-type="pmid">23033966</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trapnell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>
<source/>Genome Biol.
          <volume>14</volume>
<year>2013</year>
<fpage>R36</fpage>
<pub-id pub-id-type="pmid">23618408</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacaria</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1</article-title>
<source/>Am. J. Med. Genet. A.
          <volume>161A</volume>
<year>2013</year>
<fpage>1561</fpage>
<lpage>1568</lpage>
<pub-id pub-id-type="pmid">23703963</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langmead</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Fast gapped-read alignment with Bowtie 2</article-title>
<source/>Nat. Methods
          <volume>9</volume>
<year>2012</year>
<fpage>357</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="pmid">22388286</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langmead</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Trapnell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>
<source/>Genome Biol.
          <volume>10</volume>
<year>2009</year>
<fpage>R25</fpage>
<pub-id pub-id-type="pmid">19261174</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>RNA-Enrich: a cut-off free functional enrichment testing method for RNA-seq with improved detection power</article-title>
<source/>Bioinformatics
          <volume>32</volume>
<year>2016</year>
<fpage>1100</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="pmid">26607492</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
<source/>Bioinformatics
          <volume>30</volume>
<year>2014</year>
<fpage>923</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">24227677</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source/>Genome Biol.
          <volume>15</volume>
<year>2014</year>
<fpage>550</fpage>
<pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Uchigashima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hock</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kawasawa</surname>
<given-names>Y.I.</given-names>
</name>
<name>
<surname>Futai</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Activity-induced regulation of synaptic strength through the chromatin reader L3mbtl1</article-title>
<source/>Cell Rep.
          <volume>23</volume>
<year>2018</year>
<fpage>3209</fpage>
<lpage>3222</lpage>
<pub-id pub-id-type="pmid">29898393</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>MacKay</surname>
<given-names>D.J.C.</given-names>
</name>
</person-group>
<article-title>The role of constraints in Hebbian learning</article-title>
<source/>Neural Comput.
          <volume>6</volume>
<year>1994</year>
<fpage>100</fpage>
<lpage>126</lpage>
</element-citation>
</ref>
<ref id="bib45">
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullins</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fishell</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Unifying views of autism spectrum disorders: a consideration of autoregulatory feedback loops</article-title>
<source/>Neuron
          <volume>89</volume>
<year>2016</year>
<fpage>1131</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="pmid">26985722</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okuno</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Regulation and function of immediate-early genes in the brain: beyond neuronal activity markers</article-title>
<source/>Neurosci. Res.
          <volume>69</volume>
<year>2011</year>
<fpage>175</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="pmid">21163309</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orlando</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Solanki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Bradner</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Quantitative ChIP-seq normalization reveals global modulation of the epigenome</article-title>
<source/>Cell Rep.
          <volume>9</volume>
<year>2014</year>
<fpage>1163</fpage>
<lpage>1170</lpage>
<pub-id pub-id-type="pmid">25437568</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulsen</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Veloso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bedi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ljungman</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Tsan</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C.-W.</given-names>
</name>
<name>
<surname>Tarrier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Washburn</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</article-title>
<source/>Proc. Natl. Acad. Sci. U S A
          <volume>110</volume>
<year>2013</year>
<fpage>2240</fpage>
<lpage>2245</lpage>
<pub-id pub-id-type="pmid">23345452</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulsen</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Veloso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bedi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ljungman</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Magnuson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Ljungman</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Use of Bru-seq and BruChase-seq for genome-wide assessment of the synthesis and stability of RNA</article-title>
<source/>Methods
          <volume>67</volume>
<year>2014</year>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">23973811</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Treadwell-Deering</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Eifert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Krull</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype</article-title>
<source/>Am. J. Hum. Genet.
          <volume>80</volume>
<year>2007</year>
<fpage>633</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="pmid">17357070</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Risher</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Eroglu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Thrombospondins as key regulators of synaptogenesis in the central nervous system</article-title>
<source/>Matrix Biol.
          <volume>31</volume>
<year>2012</year>
<fpage>170</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">22285841</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanzenbächer</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Sambandan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Schuman</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Nascent proteome remodeling following homeostatic scaling at hippocampal synapses</article-title>
<source/>Neuron
          <volume>92</volume>
<year>2016</year>
<fpage>358</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">27764671</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaukowitch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Reese</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Kilaru</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Kavalali</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.K.</given-names>
</name>
</person-group>
<article-title>An intrinsic transcriptional program underlying synaptic scaling during activity suppression</article-title>
<source/>Cell Rep.
          <volume>18</volume>
<year>2017</year>
<fpage>1512</fpage>
<lpage>1526</lpage>
<pub-id pub-id-type="pmid">28178527</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slager</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Vlangos</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Finucane</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elsea</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Mutations in RAI1 associated with Smith-Magenis syndrome</article-title>
<source/>Nat. Genet.
          <volume>33</volume>
<year>2003</year>
<fpage>466</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="pmid">12652298</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soden</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid</article-title>
<source/>J. Neurosci.
          <volume>30</volume>
<year>2010</year>
<fpage>16910</fpage>
<lpage>16921</lpage>
<pub-id pub-id-type="pmid">21159962</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Supek</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bošnjak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Škunca</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Šmuc</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title>
<source/>PLoS ONE
          <volume>6</volume>
<year>2011</year>
<fpage>e21800</fpage>
<pub-id pub-id-type="pmid">21789182</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tachibana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwanari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sakihama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kodama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hamakubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shinkai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9</article-title>
<source/>Genes Dev.
          <volume>19</volume>
<year>2005</year>
<fpage>815</fpage>
<lpage>826</lpage>
<pub-id pub-id-type="pmid">15774718</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>The self-tuning neuron: synaptic scaling of excitatory synapses</article-title>
<source/>Cell
          <volume>135</volume>
<year>2008</year>
<fpage>422</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="pmid">18984155</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>The dialectic of Hebb and homeostasis</article-title>
<source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
          <volume>372</volume>
<year>2017</year>
<fpage>20160258</fpage>
<pub-id pub-id-type="pmid">28093556</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallianatos</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Farrehi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Friez</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Burmeister</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keegan</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Iwase</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Altered gene-regulatory function of KDM5C by a novel mutation associated with autism and intellectual disability</article-title>
<source/>Front. Mol. Neurosci.
          <volume>11</volume>
<year>2018</year>
<fpage>104</fpage>
<pub-id pub-id-type="pmid">29670509</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vierstra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rynes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sandstrom</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Canfield</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Stehling-Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Byron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Humbert</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution</article-title>
<source/>Science
          <volume>346</volume>
<year>2014</year>
<fpage>1007</fpage>
<lpage>1012</lpage>
<pub-id pub-id-type="pmid">25411453</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>West</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Regulation of transcription factors by neuronal activity</article-title>
<source/>Nat. Rev. Neurosci.
          <volume>3</volume>
<year>2002</year>
<fpage>921</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="pmid">12461549</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Widagdo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anggono</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity</article-title>
<source/>J. Neurochem.
          <volume>147</volume>
<year>2018</year>
<fpage>137</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">29873074</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yee</surname>
<given-names>A.X.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>Y.-T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>A metaplasticity view of the interaction between homeostatic and Hebbian plasticity</article-title>
<source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
          <volume>372</volume>
<year>2017</year>
<fpage>20160155</fpage>
<pub-id pub-id-type="pmid">28093549</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.Y.</given-names>
</name>
</person-group>
<article-title>ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title>
<source/>Bioinformatics
          <volume>31</volume>
<year>2015</year>
<fpage>2382</fpage>
<lpage>2383</lpage>
<pub-id pub-id-type="pmid">25765347</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.U.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Y.-l.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>G.-l.</given-names>
</name>
</person-group>
<article-title>Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair</article-title>
<source/>Nat. Neurosci.
          <volume>18</volume>
<year>2015</year>
<fpage>836</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="pmid">25915473</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zajaczkowski</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.-Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Leighton</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Nainar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spitale</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bredy</surname>
<given-names>T.W.</given-names>
</name>
</person-group>
<article-title>Bioorthogonal metabolic labeling of nascent RNA in neurons improves the sensitivity of transcriptome-wide profiling</article-title>
<source/>ACS Chem. Neurosci.
          <volume>9</volume>
<year>2018</year>
<fpage>1858</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="pmid">29874042</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Eeckhoute</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Nusbaum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.S.</given-names>
</name>
</person-group>
<article-title>Model-based analysis of ChIP-seq (MACS)</article-title>
<source/>Genome Biol.
          <volume>9</volume>
<year>2008</year>
<fpage>R137</fpage>
<pub-id pub-id-type="pmid">18798982</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Scholze</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>O’Keeffe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Phatnani</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Guarnieri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ruderisch</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title>
<source/>J. Neurosci.
          <volume>34</volume>
<year>2014</year>
<fpage>11929</fpage>
<lpage>11947</lpage>
<pub-id pub-id-type="pmid">25186741</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5</article-title>
<source/>J. Neurosci.
          <volume>32</volume>
<year>2012</year>
<fpage>12841</fpage>
<lpage>12847</lpage>
<pub-id pub-id-type="pmid">22973007</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="app2" sec-type="supplementary-material">
<title>Supplemental Information</title>
<p id="p0320">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figures S1–S5 and Tables S5 and S6</title></caption><media xlink:href="mmc1.pdf"></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2"><caption><title>Table S1. DESeq2 for TTX and BIC-Treated sh-Ctrl Cultures, Related to Figure 1</title></caption><media xlink:href="mmc2.xlsx"></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc3"><caption><title>Table S2. RNA-Enrich for TTX and BIC-Treated sh-Ctrl Cultures, Related to Figure 1</title></caption><media xlink:href="mmc3.xlsx"></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc4"><caption><title>Table S3. DESeq2 Data for TTX, Veh, and BIC-Treated sh-<italic>Rai1</italic> Cultures, Related to Figures 2 and 4</title></caption><media xlink:href="mmc4.xls"></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc5"><caption><title>Table S4. RNA-Enrich Data for TTX, Veh, and BIC-Treated sh-<italic>Rai1</italic> Cultures, Related to Figures 2 and 4</title></caption><media xlink:href="mmc5.xlsx"></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc6"><caption><title>Document S2. Article plus Supplemental Information</title></caption><media xlink:href="mmc6.pdf"></media></supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>We thank Dr. Saurabh Agarwal for providing technical support for BrU-seq experiments and scripts for mapping and annotating RNA-seq data. We thank Yu (Celine) Chuo for technical support in experiments and helpful discussion. We thank the Smrcka lab for neonatal rat tissue. P.M.G. was supported by a <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source> (<funding-source id="gs2">NSF</funding-source>) Graduate Research Fellowship Program (DGE #1256260). T.T. was supported by a <funding-source id="gs3">Parents and Researchers Interested in Smith-Magenis Syndrome</funding-source> (<funding-source id="gs4">PRISMS</funding-source>) post-doctoral fellowship. A.C. was supported by a <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> (<funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source>) National Research Service Award (NRSA) fellowship (18-PAF03228). M.A.W. was supported by a Summer Fellowship from the <funding-source id="gs7">University of Michigan Language, Sciences, and Arts Honors Program</funding-source>. This work was supported by the <funding-source id="gs8"><institution-wrap><institution-id institution-id-type="doi">10.13039/100008455</institution-id><institution>University of Michigan Medical School</institution></institution-wrap></funding-source> (to S.I.), the <funding-source id="gs9"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000912</institution-id><institution>March of Dimes Foundation</institution></institution-wrap></funding-source> (to S.I.), and the <funding-source id="gs10"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source> (R01DA020140 to K.S.J.; R01NS089896, R01NS116008, and R21NS104774 to S.I.; R01NS097498 to M.A.S.). We thank the members of Iwase and Sutton laboratories for discussion and support.</p>
<sec id="sec5">
<title>Author Contributions</title>
<p id="p0305">Conceptualization, P.M.G., M.A.S., and S.I.; Methodology, P.M.G., T.T., S.I., M.A.S., J.C.R.D., K.S.J., and R.K.; Validation, P.M.G., A.C., T.T., J.C.R.D., R.K., J.C.A., and M.A.W.; Formal Analysis, P.M.G., A.C., T.T., J.C.R.D., R.K., M.A.S., J.C.A., and M.A.W.; Investigation, P.M.G., A.C., T.T., J.C.R.D., R.K., J.C.A., and M.A.W.; Resources, R.J.G., K.S.J., M.A.S., and S.I.; Data Curation, P.M.G., A.C., T.T., J.C.R.D., R.K., and M.A.W.; Writing—Original Draft, P.M.G., A.C., T.T., J.C.R.D., K.S.J., M.A.S., and S.I.; Writing—Review &amp; Editing: P.M.G., A.C., T.T., J.C.R.D., R.K., M.A.W., R.J.G., K.S.J., M.A.S., and S.I.; Visualization, P.M.G., A.C., T.T., J.C.R.D., R.K., and M.A.W.; Supervision, P.M.G., M.A.S., and S.I.; Project Administration, P.M.G., T.T., M.A.S., and S.I.; Funding Acquisition, P.M.G., T.T., R.J.G., K.S.J., M.A.S., and S.I.</p>
</sec>
<sec id="sec6" sec-type="COI-statement">
<title>Declaration of Interests</title>
<p id="p0310">The authors declare no competing interests.</p>
</sec>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="app1">
<p id="p0315">Supplemental Information can be found online at <ext-link ext-link-type="uri" id="intref0055" xlink:href="https://doi.org/10.1016/j.celrep.2020.108002">https://doi.org/10.1016/j.celrep.2020.108002</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>